Analysis of California Assembly Bill 744: Telehealth by California Health Benefits Review Program
UC Office of the President
Report to California Legislature
Title
Analysis of California Assembly Bill 744: Telehealth
Permalink
https://escholarship.org/uc/item/350033k9
Author
California Health Benefits Review Program
Publication Date
2019-04-16
Data Availability
The data associated with this publication are within the manuscript.
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
  
California Health 
Benefits  
Review Program 
Analysis of California Assembly Bill 744 
Telehealth 
A Report to the 2019–2020 California State Legislature April 16, 2019 
 
 
Key Findings: 
Analysis of California Assembly Bill 744 
Telehealth 
Summary to the 2019–2020 California State Legislature, April 16, 2019 
Current as of April 16, 2019 www.chbrp.org  i 
 
                                                     
1 Refer to CHBRP’s full report for full citations and references. 
CONTEXT 
Telehealth is defined by AB 744 as “the mode of delivering 
healthcare services and public health via information and 
communication technologies to facilitate the diagnosis, 
consultation, treatment, education, care management, and 
self-management of a patient’s health care.”1 
CHBRP focuses on the most common types of telehealth 
modalities:  
 Live video — uses two-way, interactive video to 
connect users. Occurs provider-to-provider at a 
distant site or between a patient and a provider;  
AT A GLANCE 
The version of California Assembly Bill 744 analyzed 
by CHBRP would require reimbursement parity 
between telehealth services and the equivalent in-
person visit. 
1. CHBRP estimates that, in 2020, all 24.5 million 
Californians enrolled in state-regulated health 
insurance would have insurance subject to AB 
744.  
2. Benefit coverage.  More than half (51% to 
80%) of enrollees currently have coverage for 
telehealth paid at parity with equivalent in-
person services. AB 744 would not exceed  
essential health benefits (EHBs).  
3. Utilization. Of the 20% to 49% of enrollees 
receiving new coverage for various services 
reimbursed at parity under AB 744, CHBRP 
estimates a marginal increase in use among 
commercial and CalPERS enrollees ranging 
from a low of 3/1,000 emergency department 
visits, diagnostic services and other services  
to a high of 12.1/1,000 primary care and urgent 
care visits. Among Medi-Cal Managed Care 
enrollees, utilization would increase by 
2.2/1,000 outpatient mental health and 
substance use disorder visits and a high of 
51.6/1,000 primary care and urgent care visits.  
4. Expenditures. In 2020, total net annual 
expenditures would increase by $278,298,000, 
or 0.17%. 
a. Although some services are currently paid 
at parity, for services not paid at parity, 
commercial insurers and CalPERS would 
need to pay at rates that are 42% to 137% 
higher to be equivalent to the 
corresponding in-person visits. 
b. Medi-Cal Managed Care plans would need 
to pay at rates that are 15% to 30% higher 
to be equivalent to the corresponding in-
person visits.  
 
 
 
AT A GLANCE, Cont.  
 
5. Medical effectiveness. Evidence of 
effectiveness is mixed for services delivered 
via telehealth. Among the telehealth 
modalities and services reviewed, there is 
evidence that most modalities and services 
improve health outcomes. Evidence regarding 
effects on process of care, access, and 
utilization is insufficient or inconclusive for 
most modalities and services. 
6. Public health. The public health impact of AB 
744 is unknown, although CHBRP anticipates 
that some newly covered patients will be able 
to obtain more timely specialty or primary 
care, especially for those in rural regions. 
These patients will also experience reduced 
travel time and associated costs. 
7. Long-term impacts. CHBRP assumes that 
technology improvements, the 2019 Centers 
for Medicare & Medicaid (CMS) 
reimbursement policy, and continued adoption 
of value-based, bundled care reimbursement 
models will likely increase use of e-mail, 
videoconferencing, and other telehealth 
services between patients and providers. 
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 Store and forward — provider captures medical 
information (e.g., photo, recording) and transmits 
information to a remote provider for later review; 
 E-mail and synchronous text and chat 
conferencing — health system portals provide email, 
chat or text options for patients to contact providers; 
and 
 Telephone — landline, cell phone.  
Telehealth modalities may be used to facilitate patient-to-
provider or provider-to-provider communication. These 
modalities are also used to support eConsults (provider-
to-provider) and remote patient monitoring (passive 
patient-provider interaction) services. Additional definitions 
of telehealth modalities are included in Table 2 of the full 
report.  
BILL SUMMARY  
AB 744 would:  
 Require health plans and policies to reimburse 
telehealth services on the same basis and to the 
same extent the plans and policies reimburse for the 
same service through in person diagnosis, 
consultation, or treatment. 
 Allow plans and policies to apply cost-sharing to 
telehealth services, not to exceed cost-sharing for the 
equivalent in-person service.  
 Prohibit plans and policies from limiting telehealth 
services to only those provided by third-party 
providers and from denying coverage for a service 
solely because it is provided via telehealth.  
Figure A notes how many Californians have health 
insurance that would be subject to AB 744. 
Figure A. Health Insurance in CA and AB 744 
 
Source: California Health Benefits Review Program, 2019. 
Notes: *Medicare beneficiaries, enrollees in self-insured products, etc. 
IMPACTS 
Benefit Coverage, Utilization, and Cost  
Benefit Coverage 
The baseline coverage and payment parity across all 
modalities for telehealth services varied by type of health 
care service, with the fewest enrollees (50.9%) having 
coverage for radiology and lab/pathology services 
delivered via telehealth and a high of 80.3% of enrollees 
having coverage for outpatient mental health and 
substance use disorder services via telehealth. Overall, 
the majority of enrollees have coverage through health 
plans and insurers that pay providers for telehealth 
services at parity with equivalent in-person services. 
Some telehealth services may delivered through third-
party vendors (e.g., Teladoc). Approximately 10% of 
commercial insurance enrollees and 17% of Medi-Cal 
enrollees have access to these third-party services. 
CHBRP assumes that postmandate, this type of encounter 
will remain ineligible for reimbursement because the 
encounter may be with a nonbillable provider (e.g., 
because nonbillable providers tend to deliver these types 
of services or billable providers of a national vendor may 
not be licensed by California’s Business and Professions 
code). 
Medi-Cal 
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7,591,000
State-
regulated 
health 
insurance 
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24,490,000
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Utilization 
CHBRP estimates that, postmandate, telehealth visits 
would represent 5.7% of all visits for those newly covered 
enrollees due to the added coverage and reimbursement 
parity required by AB 744; this would match the utilization 
rate of those enrollees already covered at baseline. The 
increases are attributable to areas where telehealth would 
likely substitute for in-person services (i.e., teleradiology, 
telestroke, teleICU, and lab/pathology) and/or supplement 
existing in-person services (i.e. office visits, 
telepsychiatry). About 29% of the marginal increase in 
telehealth utilization is attributable to substitution and 71% 
is attributable to supplemental visits (visits previously 
provided, but not reimbursed, or not previously provided).  
Of the 20% to 49% of enrollees receiving new coverage 
for various services reimbursed at parity under AB 744, 
CHBRP estimates a marginal increase in use among 
commercial and CalPERS enrollees ranging from a low of 
3/1,000 emergency department visits, diagnostic services 
and other services to a high of 12.1/1,000 primary care 
and urgent care visits. Among Medi-Cal Managed Care 
enrollees, utilization would increase between 2.2/1,000 for 
outpatient mental health and substance use disorder visits 
and a high of 51.6/1,000 primary care and urgent care 
visits. 
The increase in telehealth services postmandate is 
accompanied by a slight decrease in the use of in-person 
services. Estimated increases are larger in the Medi-Cal 
managed care enrollee population due to a lack of current 
coverage across all modalities at parity, along with the 
lack of cost-sharing requirements in Medi-Cal. 
Per-Unit Cost 
Telehealth services not currently paid at parity with 
equivalent in-person services include office visits for 
primary and urgent care, dermatology, other specialists, 
and outpatient mental health and substance use disorder. 
To reach parity, commercial insurers and CalPERS would 
need to pay rates that are 23% to 120% higher to be 
equivalent to in-person visits for the same services. Medi-
Cal Managed Care plans would need to pay at rates that 
are 15% to 30% higher to be equivalent to the 
corresponding in-person visits. 
Expenditures 
AB 744 would increase total net annual expenditures by 
$278,298,000 or 0.17% for enrollees with DMHC-
regulated plans and CDI-regulated policies. This increase 
is primarily driven by increases of $132,415,000 (0.15%) 
in spending by private group employers, $22,526,000 
(0.24%) in spending by enrollees with individually 
purchased Covered California policies and $42,201,000 
(0.15%) in spending by Medi-Cal managed care plans.  
This increase in total net annual expenditures is due to a 
$228,853,000 change in total premiums (0.16% increase 
in total health insurance premiums paid by employers, 
Medi-Cal, and enrollees for newly covered benefits), 
adjusted by an $49,446,000 (0.34%) increase in enrollee 
expenses for covered benefits. 
Figure B. Expenditure Impacts of AB 744 
 
Source: California Health Benefits Review Program, 2019.  
Medi-Cal 
Total expenditures would increase by $42,201,000 
(0.15%) for Medi-Cal Managed Care Plans.   
CalPERS 
Total expenditures would increase by $4,879,000 (0.16%) 
for CalPERS HMO.  
Number of Uninsured in California 
Because the change in average premiums does not 
exceed 1% for any market segment, CHBRP would expect 
$137,294,000
$26,731,000
$22,626,000
$42,201,000
$49,446,000
$0
Employer Premiums
Individual Premiums
Employee Premiums
Medi-Cal managed care
plan expenditures
Enrollee Out-of-Pocket
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no measurable change in the number of uninsured 
persons due to the enactment of AB 744. 
Medical Effectiveness 
Most studies pertinent to AB 744 examine the use 
telehealth as a substitute for in-person care. In these 
cases, the relevant studies evaluated whether care 
provided via these technologies is at least as effective as 
in-person care and whether use of these technologies 
improves access to care and outcomes.  
Evidence regarding the effectiveness of telehealth 
modalities and services is mixed depending on the type of 
outcome studied: access and utilization, process of care, 
or health outcomes.  
Access and Utilization:  
 There is clear and convincing evidence that  remote 
patient monitoring is effective. 
 Preponderance of evidence that store and forward 
and eConsult are effective. 
 Preponderance of evidence that live video does not 
reduce use of in-person health care services. 
 Inconclusive evidence that e-mail, synchronous text 
and chat conferencing, telephone, and 
telerehabilitation are effective. 
 Insufficient evidence that telestroke is effective. 
Process of Care:  
 Clear and convincing evidence that live video is 
effective.  
 Preponderance of evidence that telestroke is effective.  
 Limited evidence that e-mail, synchronous text and 
chat conferencing, and telephone are effective.  
 Inconclusive evidence that store and forward is 
effective. 
 Insufficient evidence that telerehabilitation, eConsult, 
and remote patient monitoring are effective.  
Health Outcomes:  
 Clear and convincing evidence that live video and 
remote patient monitoring are effective.  
 Preponderance of evidence that telephone, telestroke, 
and telerehabilitation are effective.  
 Limited evidence that store and forward and e-mail, 
synchronous text and chat conferencing are effective.  
 And insufficient evidence that eConsult is effective.  
Public Health 
Patient access to care could improve through provider use 
of live video, store and forward, eConsults, and remote 
patient monitoring; however, there is limited or insufficient 
evidence of other modalities (e-mail, chat, texting, 
telephone) improving access to care. Therefore, the public 
health impact of AB 744 is unknown, although CHBRP 
anticipates that at least some patients would be able to 
obtain more timely specialty or primary care. Those 
patients would also experience reduced travel time and 
associated costs.  
CHBRP is unable to assess changes in public health 
outcomes due to vast differences in study quality and 
findings of effectiveness across health conditions and 
telehealth modalities. For areas where stronger evidence 
exists, such as live videoconferencing, telephone, and 
remote patient monitoring, and for certain specialty areas 
(e.g., mental health, dermatologic or diabetes care) 
enrollees could see equivalent or improved health 
outcomes as compared with in-person care.  
Long-Term Impacts 
In Year 2 of implementation, AB 744 is expected to result 
in additional use of telehealth services such that telehealth 
represents 6.54% of all visits. This is due to a 21% 
increase above the 2020 estimated share of all outpatient 
visits that are telehealth visits (5.7%). If telehealth use 
continues to expand in subsequent years, it is likely that 
increased spending on telehealth will occur. One reason is 
that CHBRP projects that the majority of growth will occur 
in new (i.e., supplemental) telehealth services.  
CHBRP assumes that technology will continue to drive 
adoption and integration of telehealth. CHBRP projects 
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that this trend, along with changes in CMS reimbursement 
policy in 2019, and continued adoption of value-based, 
bundled care reimbursement models will likely increase 
use of e-mail, videoconferencing, and other telehealth 
services between patients and providers. However, 
estimated cost-offsets from substitution and supplemental 
telehealth visits and in-person visits are unknown.
Essential Health Benefits and the 
Affordable Care Act 
AB 744 would not require coverage of a new state benefit 
mandate and appears not to exceed the definition of EHBs 
in California.   
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research staff from multiple University of California campuses to complete each CHBRP analysis. A 
strict conflict-of-interest policy ensures that the analyses are undertaken without bias. A certified, 
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approach for each report.  
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Table 1. AB 744 Impacts on Benefit Coverage, Utilization, and Cost, 2020 
  Baseline Postmandate Increase/ 
Decrease 
Percentage 
Change 
Benefit coverage 
 Total enrollees with health 
insurance subject to state-level 
benefit mandates (a) 24,490,000 24,490,000 0 0% 
 Total enrollees with health 
insurance subject to AB 744 24,490,000 24,490,000 0 0% 
 Have telehealth coverage for 
service category:         
 … Office visits – primary care 
and urgent care visits 
56.1% 100.0% 44% 78% 
 … Office visits – 
ophthalmology 
70.4% 100.0% 30% 42% 
 … Office visits – dermatology 70.4% 100.0% 30% 42% 
 … Office visits – other 
specialists 
70.4% 100.0% 30% 42% 
 … Emergency department 
visits 
55.7% 100.0% 44% 80% 
 … Cardiovascular 61.3% 100.0% 39% 63% 
 … Radiology 50.9% 100.0% 49% 96% 
 … Lab/pathology 50.9% 100.0% 49% 96% 
 … Outpatient mental health 
and SUD 
80.3% 100.0% 20% 25% 
Utilization and unit cost 
 Commercial and CalPERS 
HMOs     
  Average utilization per 1,000 
for telehealth services for 
service category         
 Telehealth services         
 …Office visits – Primary Care 
and Urgent Care Visits 52.9 65.1 12.1 23% 
 …Office visits – 
ophthalmology, dermatology, 
and other specialists 47.2 58.0 10.8 23% 
 … Outpatient mental health 
and SUD 30.5 37.5 7.0 23% 
 … Emergency department 
visits, diagnostic services and 
other services 12.7 15.6 3.0 23% 
 In-person services         
 …  Office visits – primary care 
and urgent care visits 1,081.1 1,077.5 -3.5 0% 
 …  Office visits – 
ophthalmology, dermatology, 
and other specialists 964.2 961.0 -3.2 0% 
 …  Outpatient mental health 
and SUD 622.4 620.3 -2.0 0% 
 … Emergency department 
visits, diagnostic services and 
other services 4,007.5 4,006.6 -0.9 0% 
  Average cost per telehealth 
service for service category         
 Telehealth services         
 …  Office visits – primary care 
and urgent care visits $57 $134 $77 137% 
 …  Office visits – 
ophthalmology, dermatology, 
and other specialists $66 $137 $71 109% 
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 …  Outpatient mental health 
and SUD $105 $148 $44 42% 
 … Emergency department 
visits, diagnostic services and 
other services $186 $187 $0 0% 
 In-person services         
 … Office visits – primary care 
and urgent care visits $134 $134 $0 0% 
 …  Office visits – 
ophthalmology, dermatology, 
and other specialists $137 $137 $0 0% 
 …  Outpatient mental health 
and SUD $148 $148 $0 0% 
 … Emergency department 
visits, diagnostic services and 
other services $59 $59 $0 0% 
 Medi-Cal Managed Care 
Plans     
  Average utilization per 1,000 
for telehealth services for 
service category         
 Telehealth services         
 …  Office visits – primary care 
and urgent care visits 0.0 51.6 51.6 N/A 
 …  Office visits – 
ophthalmology, dermatology, 
and other specialists 32.6 70.8 38.1 117% 
 …  Outpatient mental health 
and SUD 7.6 9.8 2.2 28% 
 … Emergency department 
visits, diagnostic services and 
other services 2.4 41.2 38.8 1619% 
 In-person services         
 … Office visits – primary care 
and urgent care visits 869.5 854.4 -15.0 -2% 
 …  Office visits – 
ophthalmology, dermatology, 
and other specialists 1,182.9 1,171.8 -11.1 -1% 
 …  Outpatient mental health 
and SUD 163.1 162.5 -0.6 0% 
 …  Emergency department 
visits, diagnostic services and 
other services 5,551.5 5,540.2 -11.3 0% 
  Average cost per telehealth 
service for service category         
 Telehealth services         
 … Office visits – primary care 
and urgent care visits $37 $37 $0 0% 
 …  Office visits – 
ophthalmology, dermatology, 
and other specialists $42 $48 $6 15% 
 …  Outpatient mental health 
and SUD $87 $87 $0 0% 
 …  Emergency department 
visits, diagnostic services and 
other services $53 $69 $16 30% 
 In-person services         
 …  Office visits – primary care 
and urgent care visits $37 $37 $0 0% 
 …  Office visits – 
ophthalmology, dermatology, 
and other specialists $48 $48 $0 0% 
 …  Outpatient mental health 
and SUD $87 $87 $0 0% 
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 … Emergency department 
visits, diagnostic services and 
other services $28 $28 $0 0% 
Expenditures 
Premiums by payer 
 Private employers for group 
insurance 
$86,438,375,000 $86,570,790,000 $132,415,000 0.1532% 
 CalPERS HMO employer 
expenditures (c) (b) 
$3,098,551,000 $3,103,430,000 $4,879,000 0.1575% 
 Medi-Cal Managed Care Plan 
expenditures 
$28,492,273,000 $28,534,474,000 $42,201,000 0.1481% 
 Enrollees with individually 
purchased insurance 
$12,045,324,000 $12,072,055,000 $26,731,000 0.2219% 
 Enrollees with group 
insurance, CalPERS HMOs, 
Covered California, and Medi-
Cal Managed Care (c) 
$2,486,222,000 $2,490,427,000 $4,205,000 0.1691% 
Enrollee expenses 
 For covered benefits 
(deductibles, copayments, etc.) 
$14,750,880,000 $14,800,326,000 $49,446,000 0.3352% 
 For noncovered benefits (d) $0 $0 $0 0.00% 
Total expenditures $159,301,797,000 $159,301,797,000 $159,580,095,000 0.1747% 
Source: California Health Benefits Review Program, 2019. 
Notes: (a) Enrollees in plans and policies regulated by DMHC or CDI aged 0 to 64 years as well as enrollees 65 years or older in 
employer-sponsored health insurance. This group includes commercial enrollees (including those associated with Covered 
California or CalPERS) and Medi-Cal beneficiaries enrolled in DMHC-regulated plans.2  
(b) Approximately 56.17% of CalPERS enrollees in DMHC-regulated plans are state retirees, state employees, or their dependents.  
(c) Enrollee premium expenditures include contributions by employees to employer-sponsored health insurance, health insurance 
purchased through Covered California, and contributions to Medi-Cal Managed Care. 
(d) Includes only expenses paid directly by enrollees (or other sources) to providers for services related to the mandated benefit that 
are not currently covered by insurance. This only includes those expenses that will be newly covered postmandate. Other 
components of expenditures in this table include all health care services covered by insurance. Unable to estimate because data 
related to non-covered benefits are not available. 
(e) Lab and pathology services represent a large source of utilization in our health care system overall. Laboratory tests can occur in 
a fairly high frequency, and the increase seen in this table is commensurate with the increases for other services. 
Key: CalPERS  = California Public Employees’ Retirement System; CDI = California Department of Insurance; DMHC = Department 
of Managed Health Care; HMO = Health Maintenance Organizations; SUD = substance use disorder. 
 
 
                                                     
2 For more detail, see Estimates of Sources of Health Insurance in California, available at  
http://chbrp.com/analysis_methodology/cost_impact_analysis.php.   
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POLICY CONTEXT 
The California Assembly Committee on Health has requested that the California Health Benefits Review 
Program (CHBRP)3 conduct an evidence-based assessment of the medical, financial, and public health 
impacts of AB 744, Telehealth. 
Bill-Specific Analysis of AB 744, Telehealth 
Bill Language Summary 
AB 744 would require reimbursement parity between telehealth services and the equivalent in-person 
visit. The full text of AB 744 can be found in Appendix A. 
AB 744 defines telehealth as “the mode of delivering healthcare services and public health via information 
and communication technologies to facilitate the diagnosis, consultation, treatment, education, care 
management, and self-management of a patient’s health care.”  
Specifically, AB 744 would:  
• Remove requirements for patients to be at a specified originating site or for providers to be at a 
specified distant site when using telehealth services.  
• Require health plans and policies to reimburse telehealth services on the same basis and to the 
same extent the plans and policies reimburse for the same service through in-person diagnosis, 
consultation, or treatment.  
• Allow plans and policies to apply cost-sharing (i.e. deductible, copay, coinsurance) to telehealth 
services, not to exceed the cost-sharing for the same services delivered through in-person 
diagnosis, consultation, or treatment.  
• Prohibit health plans and policies from placing limits on the type of telehealth setting in which 
services are provided for the patient or by the healthcare provider. 
• Additionally, although AB 744 does not require plans and policies to provide telehealth services, if 
telehealth services are provided, the telehealth services must be covered if the plan and policy 
provides coverage for the equivalent in person service.  
• Coverage of telehealth services cannot be limited to services delivered through third-party 
corporate telehealth providers and plans and policies cannot deny coverage for a service solely 
because it is provided via telehealth.  
More information about AB 744 and the changes it would make to current law is included in Table 3.  
Welfare and Institutions Code 
AB 744 removes a notification requirement that states that Medi-Cal enrollees are entitled to interactive 
communication with a provider if they are participating in asynchronous communications. CHBRP is 
unable to analyze the marginal change in utilization of telehealth services based on the removal of this 
notification requirement.   
                                                     
3 CHBRP’s authorizing statute is available at http://chbrp.org/faqs.php. 
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Relevant Populations 
If enacted, AB 744 would affect the health insurance of approximately 24.5 million enrollees (63% of all 
Californians). This represents 100% of the 24.5 million Californians who will have health insurance 
regulated by the state that may be subject to any state health benefit mandate law — health insurance 
regulated by the California Department of Managed Health Care (DMHC) or the California Department of 
Insurance (CDI). If enacted, the law would affect the health insurance of enrollees in DMHC-regulated 
plans and CDI-regulated policies, exempting specialized health plans and policies. 
Telehealth Terminology 
A standardized lexicon is still developing within the telehealth field as evidenced by the inconsistent 
classification and organization of telehealth modalities, users, and technologies. Initially, telehealth 
focused primarily on provider-to-provider communications (with or without patient presence). However, as 
technology continues to improve, telehealth’s fastest growing segments are direct-to-consumer (DTC) 
and remote patient monitoring (MedPAC, 2018). The definitions below provide an orientation to the 
relationships between modalities, services, and telehealth users, many of which intersect or overlap. 
Table 2. Telehealth Terminology Relevant to AB 744 
Modality/Service Service Description Example 
Live video 
Uses two-way, interactive video to 
connect users. Occurs provider-to-
provider at a distant site or between a 
patient and a provider. 
Patients receive counseling sessions via live 
video (telepsychiatry); or local provider 
contacts distant specialist (with or without a 
patient present) for consultation or treatment. 
Store and forward 
Provider captures medical information 
(e.g. photo, recording) and transmits 
information to a remote provider for 
later review. 
X-rays or CT scans sent to a distant 
radiologist to perform a diagnostic review. 
E-mail, synchronous 
text and chat 
conferencing 
Health system portals provide email, 
chat or text options for patients to 
contact provider 
Patient emails provider describing rash 
symptoms (with or without a picture). Provider 
responds via email with prescription for 
topical antibiotic. 
Telephone Landline, cell phone 
Patient telephones the provider for diagnosis 
and receives prescription for urinary tract 
infection. 
e-Consultation 
(eConsult) 
A form of store and forward: Referring 
provider requests uses webportal or 
EHR for clinical input from specialists, 
who answer the question, request more 
information/tests, or schedule an office 
visit. 
PCPs refer patients with A1c levels >9% for 
diabetes team e-consult. Hematology and 
endocrinology are consistently among the top 
five specialties receiving these e-consults 
across systems.  
mHealth (mobile 
health) 
A general term for the use of mobile 
phones and other wireless technology 
in medical care. 
The most common application of mHealth is 
the use of mobile devices to educate 
consumers about preventive healthcare 
services. However, mHealth is also used for 
disease surveillance, treatment support, 
epidemic outbreak tracking and chronic 
disease management 
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Modality/Service Service Description Example 
Remote patient 
monitoring 
Medical devices measure physiologic 
data, which is uploaded to provider site 
or communicated by patient to provider 
Patient or device automatically uploads 
glucose or blood pressure readings for review 
by provider. Provider–patient consultation for 
abnormal readings may follow. 
Source: California Health Benefits Review Program, 2019. Based on information from NCTRC, 2018; Player et al., 
2018; Vimalananda et al., 2015; Wicklund, 2018. 
Key: CT = computed tomography; EHR = electronic health record; PCP = primary care physician. 
Interaction With Existing Requirements 
Health benefit mandates may interact and align with the following state and federal mandates or 
provisions. 
California Policy Landscape 
AB 744 would amend: Section 2290.5 of the Business and Professions Code; Section 1374.13 of the 
Health and Safety Code; and Section 10123.85 of the Insurance Code. AB 744 would add: Sections 
1341.46 and 1374.14 to the Health and Safety Code and Section 10123.855 of the Insurance Code. 
California law and regulations 
California’s Telehealth Advancement Act of 2011 (AB 415) became law January 1, 2012. Among several 
changes, the law updated legal definitions of telehealth, removed restrictions limiting where telehealth 
services could take place, expanded relevant providers to include all state-licensed health care providers, 
and allowed for patient verbal consent in addition to written consent for use of telehealth services (CCHP, 
2015).  
Existing law defines two modalities of telehealth: synchronous interactions and asynchronous store and 
forward transfers. The definition of telehealth under current law (“information communication 
technologies”) does not specify or exclude specific telehealth modalities. Similarly, California’s existing 
definition of telehealth does not exclude evolving methods of telehealth, such as remote patient 
monitoring or mobile health, nor does it explicitly include those methods.  
State law also currently limits the coverage of telehealth modalities (store and forward4 and live video5) 
for Medi-Cal. Medi-Cal reimburses for telehealth services only under specific circumstances. Medi-Cal 
reimburses for live video and does not limit to certain specialties. For store and forward, Medi-Cal 
reimburses providers only for teledermatology, teledentistry, and teleophthalmology. The program does 
not reimburse for contacts with patients via phone, e-mail, or fax.6 However, the Department of Health 
Care Services (DHCS) recently released draft regulations that would expand coverage of and 
reimbursement for telehealth services. CHBRP analyzes the impact of proposed legislation on the current 
laws and regulations; therefore, should the DHCS regulations become finalized, the impacts CHBRP 
predicts may be altered.  
Table 3 below describes the changes AB 744 Telehealth would make to existing California regulation.  
                                                     
4 CA Business & Professions Code Sec. 2290.5, CA Welfare & Institutions Code Sec. 14132.725. 
5 CA Health & Safety Code Sec. 1374.13. CA Welfare & Institutions Code Sec. 14132.72. 
6 CA Department of Health Care Services. Medi-Cal Part 2 General Medicine Manual. Telehealth. Pg. 5. (Dec. 2013). 
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Table 3. Current California Telehealth Regulations Compared to AB 744 Telehealth.  
Current California Regulations AB 744 Telehealth 
Definitions 
Telehealth means the mode of delivering health care 
services and public health via information and 
communication technologies to facilitate the diagnosis, 
consultation, treatment, education, care management, 
and self-management of a patient’s health care while the 
patient is at the originating site and the health care 
provider is at a distant site. 
Removes requirements for patients to be at a specified 
originating site or for providers to be at a specified 
distant site. 
Asynchronous store and forward means the 
transmission of a patient’s medical information from an 
originating site to the health care provider at a distant 
site without the presence of the patient.  
Removes “asynchronous” and “without the presence of 
the patient”. 
Synchronous interaction means a real-time interaction 
between a patient and a health care provider located at 
a distant site. 
No change 
Patient rights and notifications 
Does not prevent a patient from receiving in-person 
health care delivery services after agreeing to receive 
services via telehealth.  
No change 
All laws regarding confidentiality of health care 
information and a patient’s rights to the patient’s medical 
information applies to telehealth interactions.  
No change 
Plans and policies cannot require in-person contact 
occur between a health care provider and a patient 
before telehealth services are covered.  
No change 
Plans and policies are not able to limit the settings where 
services are provided for the patient or by the health 
care provider.  
No change 
Providers are required to notify Medi-Cal enrollees that 
they are entitled to interactive communication with a 
provider if they are participating in asynchronous 
communications.  
AB 744 removes this notification requirement. 
Reimbursement policy 
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Current California Regulations AB 744 Telehealth 
N/A 
Requires health plans and policies to reimburse 
telehealth services on the same basis and to the same 
extent the plans and policies reimburse for the same 
service through in person diagnosis, consultation, or 
treatment. 
N/A 
Allows plans and policies to apply cost-sharing (i.e. 
deductible, copay, coinsurance) to the telehealth service 
that does not exceed the cost-sharing for the same 
services delivered through in-person diagnosis, 
consultation, or treatment. 
N/A 
Prohibits health plans and policies from placing limits on 
the type of applicable telehealth setting in which services 
are provided for the patient or by the health care 
provider. 
N/A 
Coverage of telehealth services cannot be limited to 
services delivered through third-party corporate 
telehealth providers and plans and policies cannot deny 
coverage for a service solely because it is provided via 
telehealth. 
Source: California Health Benefits Review Program, 2019. Based on current law and provisions of AB 744 
Telehealth.  
Note: AB 744 would amend: Section 2290.5 of the Business and Professions Code; Section 1374.13 of the Health and Safety Code; 
and Section 10123.85 of the Insurance Code. AB 744 would add: Sections 1341.46 and 1374.14 to the Health; and Safety Code 
and Section 10123.855 of the Insurance Code. 
Similar legislation to AB 744 has been introduced in California in previous years. AB 2507, introduced in 
2017, would have required reimbursement parity and specified telehealth modalities. SB 289, introduced 
in 2015, would have required reimbursement of specific telehealth services. AB 1771, introduced in 2014, 
also would have required reimbursement for telehealth services. CHBRP’s analyses of AB 2507, SB 289, 
and AB 1771 are available at www.chbrp.org.  
Other recent California legislation would have required coverage and reimbursement for telehealth for 
specific services, such as substance use disorder treatment or mental health services.  
Similar requirements in other states 
States vary greatly in the definition and regulation of telehealth. Forty-nine states and the District of 
Columbia have a codified definition of telehealth (or telemedicine) in law, regulations or in their Medicaid 
programs. Alabama is the only state that does not have an established legal definition for telehealth 
(CCHP, 2018).  
Almost all states (49) and the District of Columbia reimburse for some type of telehealth service in their 
Medicaid programs (CCHP, 2018). This is an increase from the 44 state Medicaid programs in 2014. 
Among these states, live video is the most commonly reimbursed form of telehealth, with all 49 states 
reimbursing for live video. However, the terms and conditions related to live video reimbursement vary 
widely across states. As of October 2018, California is 1 of 11 states that reimburses for store-and-
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forward in its Medicaid program; the other states are Alaska, Arizona, Connecticut, Georgia, Maryland, 
Minnesota, New Mexico, Nevada, Virginia and Washington (CCHP, 2018). Twenty states’ Medicaid 
programs reimburse for remote patient monitoring7; California does not. Eight states’ Medicaid programs 
(Alaska, Arizona, Maryland, Minnesota, Mississippi, Nevada, Virginia, and Washington) reimburse for live 
video, store and forward, and remote patient monitoring (CCHP, 2018). 
Thirty-nine states and the District of Columbia have laws in place that regulate telehealth reimbursement 
among private payers (CCHP, 2018). There is much variation among these laws; not all states require 
reimbursement parity between telehealth services and the same service delivered in-person. At least 
seven states (Arizona, Delaware, Maryland, Minnesota, Mississippi, New Jersey, and Virginia) have laws 
in place that are similar to AB 744 in that they require reimbursement parity between telehealth and in-
person services. Another seven states (Connecticut, Indiana, Montana, Nevada, North Dakota, Oregon, 
and Vermont) and the District of Columbia have laws in place that require coverage parity between 
telehealth and in-person services. 
Federal Policy Landscape 
The following federal requirements (e.g., Medicare, Veterans Affairs) provide context for the state of 
telehealth nationally, but some do not interact directly with AB 744.  
Affordable Care Act 
A number of Affordable Care Act (ACA) provisions have the potential to or do interact with state benefit 
mandates. Below is an analysis of how AB 744 may interact with requirements of the ACA as presently 
exists in federal law, including the requirement for certain health insurance to cover essential health 
benefits (EHBs).8 
Any changes at the federal level may impact the analysis or implementation of this bill, were it to pass into 
law. However, CHBRP analyzes bills in the current environment, given current law and regulations.  
Essential Health Benefits 
AB 744 would not require coverage for a new state benefit mandate and appears not to exceed the 
definition of EHBs in California. Additionally, the Centers for Medicare & Medicaid (CMS) has released 
guidance stating that antidiscrimination laws relating to service delivery method are not considered to be 
state-required benefits and would therefore not exceed EHBs.9 
Medicare 
Medicare defines “telehealth services” as services that are ordinarily furnished in-person, but are instead 
furnished using interactive, real-time telecommunication technology. Medicare restricts the use of 
telehealth by both geographic region and “originating site” (the patient’s location when they receive 
telehealth services). Medicare reimburses for certain telehealth services when the originating site is 
either: 
                                                     
7 Medical devices measure physiologic data, which is uploaded to provider site or communicated by patient to 
provider. 
8 The ACA requires nongrandfathered small-group and individual market health insurance — including but not limited 
to QHPs sold in Covered California — to cover 10 specified categories of EHBs. Resources on EHBs and other ACA 
impacts are available on the CHBRP website: http://www.chbrp.org/other_publications/index.php. 
9 CCIIO, Information on Essential Health Benefits Benchmark Plans. Available at: 
https://www.cms.gov/cciio/resources/data-resources/ehb.html. 
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• A Health Professional Shortage Area (HPSA); or 
• A county outside of a Metropolitan Statistical Area (MSA).  
The patient cannot receive reimbursable telehealth services from their home; the originating site must be 
a medical facility such as a hospital, rural health clinic, or provider’s office (CMS, 2018) 
If a patient’s originating site meets the above qualifications, Medicare will reimburse for synchronous live 
video. Medicare only reimburses for store-and-forward in telehealth demonstration programs in Alaska 
and Hawaii (CMS, 2018). 
Medicare reimburses the following providers for telehealth services that meet the above requirements 
(subject to state law):  
• Physicians; 
• Nurse practitioners (NPs);  
• Physician assistants (PAs);  
• Nurse-midwives;  
• Clinical nurse specialists (CNSs);  
• Certified registered nurse anesthetists;  
• Clinical psychologists (CPs) and clinical social workers (CSWs); and  
• Registered dietitians or nutrition professionals (CMS, 2018). 
Medicare does not currently pay for telephone or e-mail encounters between patients and providers. 
The Calendar Year 2019 Physician Fee Schedule finalized by the Centers for Medicare & Medicaid 
(CMS) in Fall 2018 expands telehealth reimbursement rules for Medicare fee-for-service and Medicare 
Advantage plans, effective January 1, 2019 (CMS, 2019). By differentiating “Medicare telehealth services” 
from “communication technology-based services,” CMS now enables providers to provide some 
telehealth services, regardless of geographic region or originating site. Newly reimbursable services 
include virtual check-ins via audio or video, remote evaluation via store and forward, and interprofessional 
internet consultation via telephone or internet (CMS, 2019). Virtual check-ins and remote evaluation must 
be provided by a billable provider. Medicare is often used as a benchmark among private insurers and 
changes in Medicare billing may lay the groundwork for billing changes among private insurers.  
Department of Veterans Affairs 
Over the past 2 decades, the federal Department of Veterans Affairs (VA) has invested heavily in and 
experimented with telehealth to address the needs of its patients, nearly half of whom live in remote rural 
areas with limited access to a VA facility (Boyle, 2019). The VA is widely considered a leader in the 
integration and use of telehealth. To improve care delivery, in 2016, the VA merged its Office of 
Telehealth Services and Connected Care into a single VA organizational unit — the Office of Connected 
Care.  In 2018, the VA delivered 2.29 million episodes of telehealth care, across more than 50 specialties 
to about 13% of veterans (782,000 patients) in their system. More than 1 million visits were delivered 
through video, a 19% increase over the previous year.   
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The VA provides multiple telehealth10 services, including: 
• Services typically provided via live video include mental health services, rehabilitation (such as for 
post-stroke patients), and surgical specialist consultations. The VA is also adding competencies 
in other areas of live videoconferencing, such as cardiology, genomics, neurology, nutrition, 
intensive care unit, and primary care.  
• Store and forward used for teleretinal imaging and teledermatology services. 
• Chronic disease management through remote patient monitoring for conditions such as diabetes, 
chronic heart failure, chronic obstructive pulmonary disease, depression, or post-traumatic stress 
disorder. 
The VA also has secure messaging features that allow patients to communicate via a web portal or their 
mobile devices; and mobile health, defined as smart phone applications for self-management of health 
conditions. 
Analytic Approach and Key Assumptions 
AB 744 does not specify which telehealth modalities would fall under the reimbursement parity provision. 
CHBRP focuses on the following common types of telehealth modalities: 
• Video communications (live video, synchronous “real time”): uses two-way, interactive video to 
connect users; 
• Store and forward: captures medical information (e.g. photo, recording) and transmits information 
to a health care provider for later review; 
• E-mail communication and synchronous text or chat conferencing; 
• Telephone communication; and 
• Services using multiple modalities, such as telestroke and telerehabilitation.  
Some services such as e-consults and remote patient monitoring may use the above types of telehealth 
but are not in themselves a modality. Additional information about and definitions of these services are 
provided below and in the Background section.  
For the purpose of this analysis, CHBRP groups e-mail and synchronous text and chat together due to 
current standards of coding and billing for electronic communication.  
Types of visits 
Unlike in previous telehealth bills introduced in California, AB 744 does not limit telehealth reimbursement 
parity to a certain type of visit (e.g., evaluation and management), patient-initiated interactions, or 
established patients. 
Some telehealth services, such as remote patient monitoring, and telephonic disease management would 
likely be provided by a third party disease management vendor or typically do not rise to the level of a 
                                                     
10 www.telehealth.va.gov. 
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billable office visit.11 These protocol-based disease management products are typically offered by nurses 
and are paid for by health plans, insurance carriers, or other payers on a contractual basis (i.e., per call or 
per member per month). CHBRP anticipates that any services focused on managing chronic disease 
being delivered by billable providers in-person or via telephone are subject to AB 744 and are at least 
partially captured in claims data. Similarly, e-consult is not a currently billable service for private 
insurance, but due to the changes in Medicare effective January 1, 2019, private insurers may enable 
billing for e-consult services in the future.  
CHBRP assumes that postmandate telehealth visits are visits that either replace existing in-person visits 
(substitute) or are new (supplemental) visits that would not have taken place in-person or would not have 
been billed as a telehealth visit. Evidence from the Government Accountability Office (GAO) suggests that 
telehealth services are already being delivered and inappropriately billed as in-person visits due to 
constraints on coverage, originating site locations, lack of knowledge by billing managers, and other 
barriers to obtaining reimbursement (GAO, 2017). Additional information about substitute and 
supplemental visits is provided in the Benefit Coverage, Cost, and Utilization Impacts section.  
Types of providers 
Although the bill language references licensed health care providers in the state and associate marriage 
and family therapists, this analysis focuses on providers eligible for reimbursement, including physicians 
and billable non-physician providers (i.e., nurse practitioner, physician assistant, mental health 
professional delivering a service with a supervising physician) to estimate the cost impact of AB 744.  
 
                                                     
11 For additional information about the types of CPT codes included in CHBRP’s analysis, please see information 
provided in Appendix C.  
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BACKGROUND ON TELEHEALTH  
This section provides context for consideration of AB 744 and includes information about patient access 
to technology, telehealth use by patients and providers, and a description of relevant social determinants 
of health and disparities among subpopulations, including rural populations. 
Access to Technology in California 
Consumer access to the Internet, telephone, or other electronic communication devices is necessary for 
communicating with physicians for health care treatment and advice via telehealth. Connectivity ranges 
between 87% and 98% of Californians depending on the data source. A report by the California Public 
Utilities Commission stated that although 98% of the state’s households have broadband access, only 
about 47% have access at speeds that meet government adequacy standards (Kollers, 2018). Table 4 
shows results from a 2017 survey of 1,628 adult Californians that found 87% reported access to 
broadband Internet connectivity at home (broadband was defined as high-speed Internet access through 
wireline or wireless) (CETF, 2017). About 70% had access through a computer or tablet and about 20% 
had access exclusively through a smart phone. See the Social Determinants of Health section for 
discussion about racial, income and urban/rural disparities. 
Table 4. California Broadband Internet Connectivity at Home, 2017 
 
 Computing Device (%) Smart Phone Only (%) Total (%) 
California 69 18 87 
Sex    
Men 68 17 85 
Women 69 19 88 
Race/ethnicity    
White 83 8 91 
Asian American 64 20 84 
Hispanic 54 28 82 
African American (a) 63 30 93 
Age group    
18–29 78 17 95 
30–39 67 23 90 
40-49 70 24 94 
50–64 67 18 85 
65+ 60 9 69 
Disability status    
Disabled 60 15 75 
Not disabled 72 19 91 
Region (b)    
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 Computing Device (%) Smart Phone Only (%) Total (%) 
Los Angeles County 65 23 88 
Inland Empire 60 20 80 
Orange/San Diego 77 9 86 
Central Valley 64 20 84 
San Francisco 78 15 93 
Other California 61 24 85 
Source: California Health Benefits Review Program based on data from the California Emerging Technology Fund 
(CETF, 2017).  
Notes: (a) Based on small sample size. 
(b) Inland counties reported less broadband use than coastal counties (82% compared with 89%) and higher use of smart phone 
only (22% as compared with 17%). 
Of the 13% of respondents reporting no internet connectivity, 69% reported cost as a reason; 42% 
reported the ability to connect through another site than home; and 19% reported no internet service 
available in their community (CETF, 2017).  
Use of Telehealth by Insurers, Providers, and Patients 
Access to and utilization of telehealth is increasing due to changes in reimbursement policies by 
purchasers and payers; greater uptake of telehealth modalities by providers; and increased use of digital 
communication by patients. Park et al. (2018) explain that adoption of telehealth is uneven across sectors 
and geographic regions. This section presents information about the use of telehealth from different 
perspectives in the health care system.  
Health Insurance Plans and Policies 
The peer-reviewed literature shows an increase in telehealth 
use nationally between 2013 and 2016 (Park et al., 2018). In 
particular, state parity laws requiring coverage of telehealth in 
parity with in-person visits by commercial insurers is 
contributing to the steady expansion of telehealth (MedPAC, 
2018).  
According to a 2017 survey conducted by the Medicare 
Payment Advisory Commission (MedPAC), most commercial plans covered at least some type telehealth 
services with limitations based on originating site, and type of clinical care (e.g., telepsychiatry, telestroke, 
evaluation and management visits, etc.) (MedPAC, 2018). In the last few years, Kaiser Permanente 
health plan reported more than 50% of its patient encounters occurred through telehealth, and 13% of 
Veteran’s Administration beneficiaries received telehealth services (Park et al., 2018). This contrasts with 
0.2% of Medicare beneficiaries using telehealth services (due in part to strict limitations on reimbursement 
for telehealth services), although the January 2019 expansion of Medicare telehealth reimbursement 
policies establishes new telehealth reimbursement codes. These new codes may increase the rate of 
utilization among Medicare enrollees and may encourage private insurers to add more reimbursement 
codes (see the Policy Context for details) (CMS, 2019).  
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Providers 
In addition to insurance coverage, providers play a key role in the telehealth market. Providers 
encompass both individual clinicians as well as hospitals and health systems. Historically, hospitals and 
health systems have been the primary adopters of telehealth and uptake among smaller clinics and 
physician groups has lagged behind. An industry-sponsored survey of health system providers concluded 
that providers continue to invest in telehealth technology, outpacing the uptake by patients (Wicklund, 
2017). Health systems respondents reported that telehealth was used most commonly for provider-to-
provider stroke consults (72%, an increase from 37% in 2016), behavioral health (41%) and intensive 
care (20%). For health systems not using telehealth, the most common barriers reported were due to 
reimbursement issues (41%), program costs (40%), and provider resistance (22%).  
Data regarding clinician uptake are sparse. CHBRP found one recent study that reported about 15% of 
physicians work in practices using telehealth for patient interactions and 11% work in practices using 
telehealth for professional consultations (Kane and Gillis, 2018). Larger practices were more likely to use 
telehealth than smaller practices (26.5% vs. 8.2%, respectively) and specialists were most likely to use 
telehealth, with radiologists (39.5%), psychiatrists (27.8%), and cardiologists (24.1%) being the most 
frequent users (Kane and Gillis, 2018).  
Patients 
Patients represent another key group that affects the telehealth market. Studies indicate that patients are 
willing and interested in participating in telehealth visits, but that current utilization is still low. For 
example, a 2017 Avizia survey reported that 18% of patient respondents used telehealth in the last year. 
Two-thirds of those surveyed reported being unsure of their insurance coverage for such services, and 
half reported finding an in-person visit more comfortable than a video visit (Wicklund, 2017). A more 
recent survey about consumer adoption of digital health care reported that video-based telehealth use 
increased from 7% in 2015 to 34% in 2018, and that, in 2018, 30% of the telehealth visits were self-pay, 
11% paid by insurance, and 10% paid directly by employers (remaining payers included “free service”, 
pharmacy, or physician) (Day and Zweig, 2018). 
Similarly, another industry-sponsored survey, by Software Advice, reported that 17% of 400 medical 
consumers had experience with telemedicine services and 72% of were unsure of their coverage 
(Hedges, 2019). Between 16% and 26% of the telehealth users cited advantages associated with 
telehealth including no need to travel, comfort of home, quick access to care and short wait time as 
benefits of telehealth and 11% cited high quality of care. However, respondents cited disadvantages, 
such as no physical exam (43%), lack of in-person interaction (27%), quality of care (13%) and having to 
use technology (9%). When asked about 10 symptoms (i.e., headache, joint pain, stomach pain/nausea, 
etc.) for which a patient might seek telehealth care, respondents preferred an in-person visit more often 
than a telehealth visit (Hedges, 2019).  
For those patients who use telehealth, patient experience studies show high levels of satisfaction (Player 
et al., 2018; Reed et al., 2018; Soegaard Ballester et al., 2017). In a survey of 1,734 patients who used a 
third-party telehealth company (41% of whom were uninsured), 94% to 99% reported being very satisfied 
with various characteristics of the telehealth service including ease of seeing images, hearing/seeing the 
provider, quality of care received, and convenience of using the service (Polinski et al., 2016). A 
randomized control trial of 205 patients undergoing knee surgery found that those using the in-home 
telerehabilitation program reported comparable levels of satisfaction with care as those who were enrolled 
in the face-to-face rehabilitation program (Moffet et al., 2017).   
Analysis of California Assembly Bill 744 
Current as of April 16, 2019 www.chbrp.org 13 
California Telehealth Experience 
A subset of telehealth is the “video-visit,” first implemented by Kaiser Permanente Northern California 
(KPNC) in 2014. Reed et al., 2018 reported that between 2015 and 2017, KPNC had 210,383 scheduled 
video visits for 152,809 patients. Of those visits, 66% of patients connected successfully (the rest 
changed their mind or connected in a different way). Among the 81,549 primary care visits, 70% were 
with the patient’s own primary care doctor, an important aspect of continuity of care. Of 994 video-visit 
patients surveyed, more than 90% reported that the visit met their needs (Reed et al., 2018).  
CHBRP found one recent study about use of the telehealth in California. This study is limited to a single 
health system that contracts with multiple distant clinic sites across California.  Kaufman et al. (2017) 
used geocoding to compare California communities with and without telehealth services to ascertain 
allocation of services by level of need. Using five measures of barriers to health care access12 to 
categorize low (1) to very high need (5) communities, the authors reported that among the 1,621 
communities across California, 340 communities were rated as “very high need” (5) and 466 rated as 
“high need” (4) of health care services. Of the 194 telemedicine clinics associated with the single health 
care system, 71.4% were in the above-average-need communities (3-5) and 33.2% were in the very-high 
-need areas (4-5). The study showed good distribution of telehealth resources by the associated health 
system; however, it also demonstrated remaining unmet needs for the majority of California’s “very high” 
and “high need communities” (Kaufman et al., 2017).  
Social Determinants of Health13 and Disparities14   
SDoH include factors outside of the traditional medical care system that influence health status and 
health outcomes. Where evidence is available, CHBRP presents the range of SDoH and related 
disparities (e.g., income, education, and social construct around age, race/ethnicity, gender, and gender 
identity/sexual orientation) that are relevant to this bill.  
Disparities in Telehealth Access by Geography and Race/Ethnicity 
The National Advisory Committee on Rural Health and Human Services 2018 report on rural health 
insurance challenges noted that rural-urban health disparities exist nationally (HRSA, 2018). Rural 
populations are generally older and sicker than urban populations, with less access to insurance and 
health care than their urban counterparts (HRSA, 2018).  CHBRP’s 2016 analysis of AB 2507 reported 
similar conclusions for rural Californians. Specifically, residents of rural communities in California 
experience poorer health status compared to residents of urban communities, such as higher self-
reported poor health status (6.1% in rural vs. 4.4% in urban), recent mental health issues (37.8% rural vs. 
34.1% urban), physical health issues (52.8% rural vs. 40.3% urban) and recent inability to engage in 
work, recreation, or self-care (27.0% rural vs. 21.4% urban) (CalSORH, 2013).  
                                                     
12 Barriers were income, culture (language and race); education (< high school diploma); insurance (unemployment 
and uninsured); and housing (rental tenure).  
13 CHBRP defines social determinants of health as conditions in which people are born, grow, live, work, learn, and 
age. These social determinants of health (economic factors, social factors, education, physical environment) are 
shaped by the distribution of money, power, and resources and impacted by policy (adapted from Healthy People 
2020, 2015; CDC, 2014). See SDoH white paper for further information.  
14 Several competing definitions of “health disparities” exist. CHBRP relies on the following definition: 
“Health disparities are potentially avoidable differences in health (or health risks that policy can influence) between 
groups of people who are more or less advantaged socially; these differences systematically place socially 
disadvantaged groups” at risk for worse health outcomes (Braveman, 2006). 
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Travel barriers and inadequate provider–patient ratios are telehealth-relevant factors that contribute to 
rural health disparities (Marcin et al., 2016; Weinhold and Gurtner, 2014). About 14% (5 million) of 
California’s 38 million residents live in rural areas (CalSORH, 2013); and in about two-thirds of counties, 
the number of physicians per capita is less than what is considered adequate to meet demand (Coffman 
et al., 2018; CHCF, 2012).  
Telehealth may help to overcome some of the disparities in health care access by redistributing 
knowledge and expertise when and where it is needed, including rural areas of California (Marcin et al., 
2016; Nesbitt, 2012). However, data show that California racial/ethnic and geographic disparities remain 
regarding the availability and quality of connectivity (cellular data plans and broadband) (Lopez, 2019). 
Reliable broadband is still generally less available in rural areas. This impedes both patient and clinician 
access to health care support. A national survey of consumers’ video-telehealth-use found a geographic 
disparity; among those aged 18-34 years, 60% of urban residents reported using video telehealth 
compared with 36% of rural residents. Similarly, for those aged 35 years and older, 46% of urban 
residents reported using video telehealth versus 17% of their rural counterparts (Day and Zweig, 2018). 
Additionally, the quality of connectivity can inhibit the use of telehealth. Because U.S. fixed broadband 
connections are faster than mobile connections, smart phone-only access can limit some people’s access 
to telehealth. Table 4 shows a disparity in access for African Americans, Hispanics, and Asian Americans 
who use smart phones-only at a higher rate than whites. Similarly, those in rural regions have higher 
rates of smart phone-only use than their urban counterparts.  
California entities continue efforts to develop and diffuse telehealth services across the state especially in 
rural areas, including a coordinated initiative from the California Health Care Foundation, California 
Telehealth Resource Center, and the Center for Care Innovations (CHCF, 2018). 
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MEDICAL EFFECTIVENESS 
As discussed in the Policy Context section, AB 744 would require state-regulated health insurance to 
cover and reimburse telehealth services at parity with services delivered in-person, principally telephone 
and electronic diagnosis, consultation, treatment, education, care management and self-management 
encounters delivered by physicians or billable non-physician providers. Because CHBRP had conducted 
previous medical effectiveness reviews through literature searches on this topic in 2014, 2015, and 2016, 
the current medical effectiveness review summarizes findings from the literature from 2016 to the present 
on the effectiveness of the common telehealth modalities as discussed in the Policy Context. This review 
encompasses studies of patients with a wide range of diseases and conditions because AB 744 would 
require coverage and reimbursement for telehealth modalities for all enrollees.  
Research Approach and Methods 
Studies of telephone, live videoconferencing, store and forward, e-mail, synchronous text or chat 
conferencing, telestroke systems, telerehabilitation, electronic consults, and remote patient monitoring, 
were identified through searches of PubMed, Web of Science, Scopus, EconLit, the Cumulative Index of 
Nursing and Allied Health Literature, and PsycINFO. Websites maintained by the following organizations 
that produce and/or index meta-analyses and systematic reviews were also searched: the Agency for 
Healthcare Research and Quality (AHRQ), the International Network of Agencies for Health Technology 
Assessment (INAHTA), the National Health Service (NHS) Centre for Reviews and Dissemination, the 
National Institute for Health and Clinical Excellence (NICE), and the Scottish Intercollegiate Guideline 
Network. The current search was limited to abstracts of peer-reviewed research studies that were 
published in English in 2016 through present. For studies published prior to 2016, CHBRP relied on 
literature searches conducted in 2014, 2015, and 2016 for reports on previous bills regarding coverage 
for telehealth services.  
Of the 2719 articles found in the current literature review, 650 were reviewed for potential inclusion in this 
report. Studies were eliminated because they did not report findings from clinical research studies, were 
of poor quality, or did not focus on the telehealth modalities relevant to AB 744. The 41 studies previously 
included in the medical effectiveness review for AB 2507 (2016) and SB 289 (2015) were also 
reconsidered. In total, 66 studies were included in the medical effectiveness review for AB 744, based on 
the quality of the studies and their relevance to AB 744. When systematic reviews had inclusion criteria 
broader than the mandate of this bill, CHBRP only summarized findings from the relevant studies.  
The conclusions below are based on the best available evidence from peer-reviewed and grey literature. 
Unpublished studies are not reviewed because the results of such studies, if they exist, cannot be 
obtained within the 60-day timeframe for CHBRP reports. 
Key Questions 
1. What are the effects of the use of telehealth modalities for persons with all diseases and 
conditions? 
a. What are the effects on access to care and utilization, (e.g., wait time for specialty care, 
or number of outpatient, emergency department visits and hospitalizations)?  
b. What are the effects on process of care, including treatment adherence and accuracy of 
diagnoses and treatment plans? 
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c.  What are the effects on health outcomes, including both physiological measures and 
patient-reported outcomes? 
2. Are there any harms associated with use of telehealth modalities? 
Methodological Considerations 
Most studies pertinent to AB 744 examine the use of e-mail, live videoconferencing, store and forward, 
synchronous text or chat conferencing, telestroke, telerehabilitation care, e-consultation (eConsults), or 
remote patient monitoring as a substitute for in-person care. In these cases, the relevant studies 
evaluated whether care provided via these technologies is at least as effective as in-person care and 
whether use of these technologies improves access to care and outcomes. Some studies, especially 
studies of telestroke care, e-mail and synchronous text or chat conferencing, assess the effect of the 
technology to supplement in-person care; these studies evaluate whether adding these technologies 
improves processes of care and health outcomes relative to receiving in-person care alone.  
Most of the literature reviewed by CHBRP consisted of systematic reviews of randomized controlled trials. 
Randomization of subjects substantially limits the possibility of selection bias, which occurs when people 
in intervention and comparison groups are not equivalent in all respect except receipt of the treatment. 
Motivation may be an important form of selection bias for studies of telehealth because people who use 
telehealth may be more motivated to improve their health than people who do not receive the treatment. 
Random assignment to receipt of telehealth services or a control condition increases the likelihood 
participants in intervention and control groups are equally motivated to improve their health. However, in 
some cases, most notably email and eConsults, the literature consists of studies in which subjects were 
not randomized. Motivation could affect the results of studies of email because patients who are more 
motivated to improve their health may be quicker to contact their providers and more willing follow their 
advice. Selection bias could occur in one of two ways for eConsults, if primary care providers have 
discretion over which patients receive eConsults. Primary care physicians may preferentially refer more 
severely ill patients for eConsults if they feel confident treating less severely ill patients. Conversely, 
primary care physicians may request eConsults for less severely ill people and in-person visits for more 
severely ill people. 
A major methodological limitation of the literature is the pace of technological change. By the time a 
research study is published, the technology under study is sometimes outdated, making it difficult to draw 
conclusions about the medical effectiveness of current technologies. Another important limitation of the 
studies is the inability to disaggregate the mandated services from other interventions, such as an 
integrated web portal that includes e-mails as well as information about self-care, access to test results, 
and ability to refill prescriptions. 
The literature search for AB 744 used general terms for telehealth services because the bill would apply 
to coverage for telehealth services for any disease or condition. This broad search strategy may have 
failed to retrieve peer-reviewed literature that was indexed using terms associated with particular 
diseases or conditions. 
Outcomes Assessed 
Three sets of outcomes assessed by studies included in this review were considered separately: (1) 
access to care and utilization outcomes, such as wait time for specialty care, or number of outpatient, 
emergency department visits and hospitalizations; (2) process of care outcomes, including treatment 
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adherence and accuracy of diagnoses and treatment plans; and (3) health outcomes, including both 
physiological measures and patient-reported outcomes. 
Study Findings15 
The findings are summarized by the following groupings of telehealth modalities: (1) live 
videoconferencing (2) store and forward (3) e-mail, and synchronous text or chat; and (4) telestroke, (5) 
telerehabilitation care, (6) electronic consultation (eConsult), and (7) remote patient monitoring. The 
findings from telestroke and telerehabilitation are presented separately because delivery of these services 
involve multiple telehealth modalities and the literature does not report findings separately for specific 
modalities. Telerehabilitation encompasses a range of rehabilitation services including remote patient 
monitoring, assessment, consultation and education through any of the telehealth modalities discussed. 
Telestroke involves a remote neurologist offering services to a geographically distant hospital through a 
variety of different modalities including telephone, videoconferencing and teleradiology.  In addition, 
findings for electronic consultation are summarized separately from findings for email and synchronous 
text and chat, because electronic consultation is asynchronous, consultative, provider-to-provider 
communication within a shared electronic medical record or web-based platform. Because patient portals 
are necessary for increased information security, most studies of the effectiveness of e-mail have 
assessed patient-to-provider communication through a web portal that patients could access directly. 
Findings for Live Videoconferencing  
Access to care and utilization 
An analysis of baseline data from an RCT (479 patients) of live videoconferencing for headache 
estimated the potential reductions in travel distance and travel time associated with substituting live 
videoconferencing for in-person visits with a specialist, Muller et al. (20176) reported that for persons in 
rural areas of northern Norway live videoconference consultations could result in a median reduction in 
travel distance of 526 kilometers and a reduction in median travel time of 7.8 hours. 
Previous CHBRP reviews of studies of live videoconferencing used in place of in-person care identified 
one study that showed improvements in timely treatment compared to outpatient specialty care (Ferrer-
Roca et al., 2010). Four studies found that live videoconferencing was not associated with changes in 
hospitalization, emergency department visits, visits to specialists for outpatient care, or primary care visits 
(Leimig et al., 2008; Modai et al., 2006; O’Reilly et al., 2007; Wallace et al., 2004).  
Process of care 
In a systematic review of neurocognitive test assessment administered via videoconferencing for patients 
with mild cognitive impairment, Alzheimer's disease, and/or substance use disorder, Brearly et al. (2017: 
12 studies; 497 participants) found that there was no significant difference in test scores based  on 
assessments made by live videoconference visits and test scores based on in-person assessments.  
However, Brearly et al. reported that studies with older participants (65 years and older) and slower 
                                                     
15 The following figures in this section summarize CHBRP’s findings regarding the strength of the evidence for the 
effects of telehealth modalities addressed by AB 744. For test, treatments, and services for which CHBRP concludes 
that there is clear and convincing, preponderance, limited, or inconclusive evidence, the placement of the highlighted 
box indicates the strength of the evidence. If CHBRP concludes that evidence is insufficient, a figure that states 
“Insufficient Evidence” will be presented. 
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internet connections reported more variability in their findings which suggests that demographic 
characteristics of the patient population and access to internet could impact the accuracy of 
neurocognitive tests administered via live videoconferencing. 
In a 2019 retrospective cohort study using claims data (528,213 total pediatric visits), Ray et al. (2019) 
compared the quality of antibiotic prescribing for acute respiratory infections among children in three 
different health care settings: live videoconferencing telehealth consultations, urgent care, and primary 
care provider offices. The study reported that clinicians who cared for children via live videoconferencing 
were less likely to prescribe antibiotics in a manner that was consistent with clinical practice guidelines 
than clinicians who cared for children in urgent care or primary care settings (59% of telemedicine visits 
versus 67% urgent care and 78% primary care provider visits). For visits with a diagnosis of streptococcal 
pharyngitis (strep throat), live videoconferencing providers were less likely to order a streptococcal test to 
confirm the diagnosis (4% of telemedicine visits versus 75% urgent care and 68% primary care provider 
visits). The lack of use of laboratory testing to confirm this diagnosis could have led live 
videoconferencing providers to prescribe antibiotics unnecessarily because some children who they 
suspected had strep throat may not have had it. Antibiotics are not indicated if a child has a sore throat 
that is not caused by streptococcal bacteria. 
The 2016 report for AB 2507 found two systematic reviews and one randomized controlled trial (RCT) 
(Fortney, 2015; Simpson and Reid, 2014; Warshaw et al., 2011) that addressed use of live 
videoconferencing in place of in-person care on processes of care. These studies found diagnoses via 
patient-physician live videoconferencing for dermatology are highly accurate (Warshaw et al., 2011: 10 
studies; 1,290 subjects), that therapeutic relationships between providers and clients are at least as 
strong as with in-person psychotherapy among persons with a wide variety of mental health conditions 
(Simpson and Reid, 2014: 23 studies), and that there are no statistically significant differences among 
intervention and control groups in medication adherence or number of prescribed medications for 
veterans diagnosed with post-traumatic stress disorder (PTSD) (Fortney et al., 2015: 265 subjects). 
Health outcomes 
CHBRP found three RCTs published since 2016 that examined the effect of live videoconferencing on 
health outcomes (Maieritsch et al.,2016; Taylor-Gjevre et al., 2017; Tsai et al., 2017). 
Researchers who conducted an RCT of veterans randomized to receive cognitive processing therapy 
(CPT) for PTSD in-person or over live videoconferencing, reported that CPT via videoconferencing may 
be equivalent to in-person care. There were significant decreases on post-treatment measures of 
depression and PTSD among both veterans who received CPT via live videoconferencing and those who 
were treated in person. However, the sample size was insufficient to conclude that the treatments were 
equivalent due to high dropout rates among both groups of veterans (43.3% across the study). 
(Maieritsch et al.,2016: 51 patients).  
The authors of RCT that compared rheumatoid arthritis patients allocated to either video‐conferencing or 
in-person care, researchers reported no significant differences between the groups in disease activity 
measures, quality of life, or patient satisfaction (Taylor-Gjevre et al., 2017: 85 patients).  
One RCT randomized people with chronic obstructive pulmonary disease (COPD) to receive either a 
supervised home-based exercise training program via real-time videoconferencing group three times a 
week or to receive usual care without exercise training. The researchers found that people who received 
home-based exercise training via real-time videoconferencing group had significantly better scores on 
measures of exercise endurance and self-efficacy than people in the control group (Tsai et al., 2017: 36 
patients). 
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Literature reviews that CHBRP conducted for its reports on SB 289 and AB 2507 identified a large body 
of evidence on the effects of live videoconferencing on health outcomes, including numerous RCTs and a 
systematic review comparing live videoconferencing to in-person care (Ferrer-Roca et al., 2010; Garcia-
Lizana and Munoz-Mayorga, 2010; Harrison et al., 1999; Kairy et al., 2009; Morland et al., 2010, 2014; 
Wallace et al., 2004). These studies report that quality of life and clinical outcomes, such as severity of 
depression symptoms, are similar between people who participate in live videoconferencing and people 
who receive in-person care. 
CHBRP also identified two studies that found that live videoconferencing was associated with better 
health outcomes than usual care. One multisite RCT found that veterans receiving psychological care via 
live videoconferencing had significantly larger decreases in scores measuring severity PTSD compared to 
those receiving usual care (Fortney et al., 2015). Another RCT of live videoconferencing for children with 
attention deficit/hyperactivity disorder (ADHD) and their caregivers found that receipt of live 
videoconferencing was associated with greater reductions in ADHD severity, hyperactivity, oppositional 
defiant disorder and inattention than the usual care (Myers et al., 2015).  
Summary of findings regarding the effectiveness of health services delivered by live 
videoconferencing: There is a preponderance of evidence based on 6 studies that care delivered by live 
video conferencing is at least as effective as in-person care for access to care and utilization.  
There is clear and convincing evidence from a systematic review of 10 studies that dermatology 
diagnoses made via live videoconferencing are as accurate as diagnoses made during in-person visits. 
There is a preponderance of evidence from a systematic review of 12 studies that scores on 
neurocognitive tests administered via live videoconferencing are similar to scores obtained when tests are 
administered in person. 
There is clear and convincing evidence based on 13 studies that mental health services for ADHD 
depression, and PTSD delivered by live video conferencing are at least as effective as in-person care for 
processes of care and health outcomes.  
There is limited evidence based on findings from 2 small RCTs that care delivered by live video 
conferencing is at least as effective as in-person care for health outcomes among persons with 
rheumatoid arthritis and COPD.  
Figure 1. Effectiveness of Health Services Delivered by Live Videoconferencing 
 
 
Findings for Store and Forward 
While teleradiology is the most widely recognized and used type of store and forward consultation, 
usually between providers, CHBRP found no recent high quality studies of teleradiology that reported 
outcomes on access to care and utilization, process of care, or health outcomes. Most studies of store-
and-forward consultation concern teledermatology or teleophthalmology.   
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Access to care and utilization 
The 2015 report for SB 289 found a systematic review about the impact of store and forward dermatology 
care on access to care. The studies consistently found that teledermatology was associated with shorter 
time to treatment as measured by time until appointment, biopsy, surgery, or other intervention (Warshaw 
et al., 2011: 42 studies; 6,634 subjects).  
A more recent systematic review and meta-analysis on teledermatology (Finnane et al., 2017: 21 studies) 
found seven studies that reported that store and forward teledermatology reduced wait times compared to 
in-person appointments, diagnosis, and surgery.  
A recent systematic review and meta-analysis of teleophthalmology examined patients receiving care 
from any trained provider through teleophthalmology compared to in-person care (Kawaguchi et al., 2018: 
2 studies; 626 patients). The authors found teleophthalmology increases the odds of having a screening 
eye examination for diabetic retinopathy (Kawaguchi et al., 2018). In one study, 77% percent of the 
teleophthalmology patients compared to 14% of in-person care patients received a screening. The other 
study reported 94% teleophthalmology patients compared to 56% in-person care patients received a 
screening, respectively (p < 0.001).  
Process of care 
In studies of store and forward technology, findings regarding diagnostic accuracy are inconsistent across 
medical specialties. A large RCT cited in the AB 2507 report found very high reliability between store and 
forward and in-person dermatology for both diagnosis and treatment plans (Nami et al., 2015). One small 
cohort study that compared in-person visits with a physician to store and forward and videoconferencing 
methods to diagnose dermatological conditions found a 100% rate of agreement between the 
consultation types, 96% rate of agreement for history-taking and physical examination, and 96% for the 
investigations, diagnosis, management plan, and the treatment prescribed (Seghers et al., 2015). 
However, a systematic review of the use of store and forward in dermatology found poorer accuracy 
compared to in-person diagnosis, especially for malignant and premalignant lesions (Warshaw et al., 
2011;42 studies; 6634 subjects).A recent meta-analysis (Finnane et al., 2017: 8 studies) also found the 
diagnostic accuracy of in-person  diagnosis is higher (67% to 85% agreement with reference standard, 
Cohen κ, 0.90) when compared with teledermatology (51% to 85% agreement with reference standard, κ, 
0.41–0.63) for the diagnosis of skin cancer.  
Studies of use of store and forward for other conditions have found that diagnoses are at least as 
accurate as in-person consultations. Studies included in the literature review for CHBRP’s report for AB 
2507 found that store and forward diagnosing has been shown to be highly accurate in diabetic 
retinopathy and pediatric heart murmurs (Dahl et al., 2002; Saari et al., 2004). More recently, Kawaguchi 
(2018) found no statistically significant difference between the ability of teleophthalmology and in-person 
examination on an ophthalmologist’s ability to detect choroidal neovascularization. 
Health outcomes 
The evidence for the effect of store and forward technology on health outcomes is limited to dermatology 
and ophthalmology. CHBRP found no studies published since 2016 that examined the effect of store-and-
forward technology on health outcomes. 
For the 2015 report for SB 289, CHBRP found one systematic review that reported insufficient evidence 
to evaluate clinical outcomes of store and forward teledermatology (Warshaw et al., 2011). Another RCT 
found that teledermatology was equivalent to in-person care, with respect to both disease-specific and 
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general health outcomes (Whited et al., 2013a,b). A small cohort study comparing store-and-forward to 
in-person dermatological diagnosis reported no adverse or harmful events for patients using store-and-
forward modality for dermatological diagnoses (Seghers et al., 2015). 
Summary of findings regarding the effectiveness of health services delivered by store and 
forward: There is limited evidence that health services delivered by store and forward are at least as 
effective as in-person care based on 13 studies. Although there is evidence that store and forward 
improves access to care and utilization, the findings for processes of care are inconsistent and findings 
regarding health outcomes are limited to dermatology and ophthalmology. Two systematic reviews have 
found that diagnoses of dermatological conditions made via store and forward are less accurate than 
diagnoses that are made during in-person visits, especially for malignant and premalignant lesions. 
Figure 2. Effectiveness of Health Services Delivered by Store and Forward 
 
 
Findings for E-Mail, Synchronous Text and Chat Conferencing 
CHBRP found no studies examining of the effect of synchronous text or chat conferencing on access to 
care and utilization of health services, process of care or health outcomes. 
Access to care and utilization 
CHBRP found no studies published since 2016 that examined the effect of e-mail, and synchronous text 
or chat conferencing on access to care and utilization of health services. 
For the 2015 report for SB 289, CHBRP identified several studies of e-mail access to physicians in the 
United States and conducted within an integrated health system that provided email access to physicians 
as part of a multifaceted web portal (such as Kaiser). The findings from these large and well-designed 
studies were also inconsistent, with one showing a decrease in primary care visits, one showing no 
difference, and two showing an increase in visits associated with patients’ use of e-mail to access primary 
care providers (Liss et al., 2014; North et al., 2014; Palen et al., 2012; Zhou et al., 2007).  
Process of care 
CHBRP found no studies published since 2016 that examined the effect of e-mail, and synchronous text 
or chat on process of care. 
The 2015 report for SB 289 reported findings from studies of patients with diabetes with e-mail access to 
physicians via a multifaceted web portal. These studies found that people who had email access to their 
physicians had better screening adherence relative to those without such access, but these studies could 
not distinguish e-mail use from other features of the web portal, such as reminder notices or electronic 
appointment scheduling (Bredfeldt et al., 2011; Harris et al., 2013; Zhou et al., 2010). Moreover, two of 
these studies had poorly controlled comparison groups, which limits the reliability of the findings. It is also 
difficult to generalize from people with diabetes to the entire population of insured individuals.  
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Health outcomes 
CHBRP found no studies published since 2016 that examined the effect of e-mail, and synchronous text 
or chat communication on health outcomes for the general population. 
For the 2015 report for SB 289, CHBRP found five studies of the effect of e-mail communication as part of 
a multifaceted web portal on health outcomes among people with diabetes. These studies consistently 
found that use of secure e-mail was associated with better glycemic control as measured by HbA1c. 
There was less consistency in the findings regarding other conditions, such as hypertension or 
hyperlipidemia (Harris et al., 2009, 2013; Lau et al., 2014; Ralston et al., 2009; Zhou et al., 2010).  
Summary of findings regarding the effectiveness of health services delivered by e-mail, 
synchronous text, and chat conferencing: CHBRP concludes that there is inconclusive evidence that 
health services delivered by email, synchronous text, and chat conferencing improves access to care and 
utilization.   
Diabetes is the only condition for which the impact of care provided by email, synchronous text, and chat 
has been studied. For this population, there is a limited evidence that email, synchronous text, and chat 
improve adherence to screening recommendations and a preponderance of evidence that these 
telehealth modalities are associated with better glycemic control. 
Figure 3. Effectiveness of Health Services Delivered by E-Mail, Synchronous Text, and Chat 
Conferencing 
 
 
Findings for Telephone 
Access to care and utilization 
CHBRP found no studies published since 2016 that examined the effect of telephone-based telehealth on 
access to care and utilization of health services. 
The 2015 report for SB 289 found inconclusive evidence from RCTs and time-series studies of the effect 
of telephone consultation services on access to care and utilization, with studies showing different effects 
for use of the same type of service (e.g., emergency department, hospitalization, or primary care) (Bunn 
et al., 2004; Flores-Mateo et al., 2012). Of the five studies that examined physician visits, Bunn et al. 
(2004) reported that three found a decrease in visits to primary care physicians and two found a 
significant increase in return visits. Additionally, of the seven studies examining emergency department 
visits, six showed no difference between telephone triage and normal care. 
Processes of care 
CHBRP found no studies that examined the effect of patient-initiated telephone-based telehealth on 
process of care. 
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Health outcomes 
The 2016 report for AB 2507 found telephone consultations were as effective as in-person consultations 
based on three studies examining of the effect of telephone-based telehealth on health outcomes 
(Akobeng et al., 2015; Fann et al., 2015; Kotb et al., 2015). An RCT in the United Kingdom found 
telephone consultations were as effective as in-person consultations for children and adolescents with 
inflammatory bowel disease in regards to improvements in quality of life (Akobeng et al., 2015). Another 
RCT assessed the differences in mental health outcomes among patients with traumatic brain injury and 
major depressive disorder diagnoses who were randomized to receiving telephonic cognitive behavioral 
therapy (CBT), in-person CBT, or usual care (consisting of phone notifications regarding depression 
status, and encouragement to continue using rehab/primary care resources plus mental health/traumatic 
brain injury referrals). The study found that participants who received telephonic CBT reported 
significantly more symptom improvement and greater satisfaction with depression care than people who 
received usual care (Fann et al., 2015). Similarly, a meta-analysis of 30 RCTs that directly compared the 
effectiveness of forms of telemedicine for patients with heart failure found that structured telephone 
support significantly reduced the odds of death (15 RCTs), hospitalizations due to heart failure (11 RCTs), 
and all-cause hospitalization(12 RCTs) compared to usual care (Kotb et al., 2015).  
In a meta-analysis (11 RCTs; 1,104 subjects), Proctor et al. (2018) found a moderately better scores on a 
measure of depression for patients who received telephone psychotherapy interventions and a small to 
moderately better short-term scores on measures of fatigue, quality of life, multiple sclerosis symptoms, 
physical activity, and medication adherence, in people with multiple sclerosis compared with controls and 
other interventions (Proctor et al., 2018). 
Summary of findings regarding the effectiveness of health services delivered by telephone: 
CHBRP concludes that, for the diseases and conditions studied, findings from studies of the effect of 
telephone consultations on access to care and utilization are inconsistent; therefore, the evidence that 
medical care provided by telephone compared to medical care provided in person is inconclusive.  
There is insufficient evidence to determine whether services provided by telephone are as effective as 
medical care provided in person for processes of care. CHBRP notes that the absence of evidence does 
not mean there is no effect; it means the effect is unknown. 
CHBRP concludes that, for the diseases and conditions studied, the preponderance of evidence from 
studies of the effect of telephone consultations suggests that telephone consultations were at least as 
effective as in-person consultations on health outcomes. 
 
Figure 4. Effectiveness of Health Services Delivered by Telephone 
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Findings for Telestroke 
Access to care and utilization 
Access to telestroke services enables people who have a stroke to obtain specialized stroke care at a 
local hospital instead of traveling a longer distance to a comprehensive stroke center.  
One cross sectional study examining access to telestroke networks using geoinformatics in Ontario, 
Canada, found that adding telestroke services increases the percentage of people in the province who 
are within 30-minutes of a hospital providing specialized care for stroke. In the study, 71.86% of the 
population was within a 30-minute drive of a regional or district stroke center. When the telestroke 
program was included, 91.28% of the population was within 30-minutes of a hospital providing specialized 
care for stroke (Jewett et al., 2017).  
Al Kasab et al. (2017: 7,694 consults) reported a substantial reduction (from 36% to 14%) in the 
percentage of patients transferred of from community hospitals to an academic health center following the 
implementation of web-based telestroke program that allows patients presenting with acute ischemic 
stroke at a rural hospital to receive consultation within minutes from a neurologist with expertise in the 
care of people with acute stroke. The program has reduced travel time by enabling more people with 
acute stroke who live in rural areas to be treated safely and effectively in local hospitals. 
Process of care 
The findings for telestroke process of care and health outcomes are based on two systematic reviews and 
meta-analyses (Baratloo et al., 2018: 26 studies; 6,605 patients; Kepplinger et al., 2016: 7 studies; 1,863 
patients). These studies examine telestroke compared to acute stroke care at a comprehensive stroke 
center with access to thrombolysis and specialized stroke expertise. 
It is widely accepted that in acute stroke, time-to-treatment is important and that the earlier intravenous 
thrombolysis (IVT) treatment is administered, the better the outcome (Jauch et al., 2013). One large meta-
analysis (Baratloo et al., 2018: 9 studies; 3,193 patients) found that onset to door duration (OTD) (5 
studies;833 patients) was significantly faster (10 minutes) for the telemedicine-guided thrombolysis 
patients compared to patients with thrombolysis performed at a comprehensive stroke center.  
Additionally, hospital length of stay (9 studies; 2,850 patients) was significantly shorter (-0.55 days).  
Health outcomes 
Health outcomes associated with telestroke systems have been well studied. Two meta-analyses 
examined the effect of telestroke on mortality (Baratloo et al., 2018: 9 studies; 3,193 patients; Kepplinger 
et al., 2016: 3 studies; 1,490 patients) and found no significant difference in 90-day mortality between 
telemedicine-guided thrombolysis compared to thrombolysis performed at a stroke center. One meta-
analysis (18 studies; 4,907 patients) also found no significant difference in in-hospital mortality for 
telemedicine-guided thrombolysis compared to thrombolysis performed at a stroke center or care at a 
stroke center (Baratloo et al., 2018). 
Both meta-analyses also found no significant difference in symptomatic intracranial hemorrhage (sICH), a 
serious complication of intravenous thrombolysis treatment (Baratloo et al., 2018: 21 studies; 4,022 
patients; Kepplinger et al., 2016: 4 studies;1,489 patients), and favorable clinical outcomes on the NIH 
Stroke Scale (NIHSS) or the modified Rankin scale (mRS), at discharge and at 30-day follow-up for 
telemedicine-guided thrombolysis patients compared to patients with thrombolysis performed at a 
comprehensive stroke center (Baratloo et al., 2018; Kepplinger et al., 2016).  
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Summary of findings regarding the effectiveness of telestroke services: There is limited evidence 
that telestroke can improve access to care and utilization of health services. There is a preponderance of 
evidence based on 2 large systematic reviews and meta analyses of 33 studies that health services 
delivered by telestroke systems are at least as effective as in-person care at a comprehensive stroke 
center for processes of care and health outcomes, including onset to door duration (OTD), hospital length 
of stay, functional independence, and mortality. 
Figure 5. Effectiveness of Health Services Delivered by Telestroke 
 
 
Findings for Telerehabilitation  
Access to care and utilization 
CHBRP found no studies published since 2016 that examined the effect of telerehabilitation on access to 
care and utilization of health services. 
CHBRP’s literature review for SB 289 identified one systematic review of studies of telerehabilitation 
(Kairy et al., 2009). The authors of the systematic review found that the studies they included in their 
review reported inconsistent findings regarding the impact of telerehabilitation on visits to emergency 
rooms and physician’s offices. 
Process of care 
In a study of the accuracy of diagnoses of musculoskeletal disorders of the knee, Richardson et al. (2017) 
conducted a repeated-measures design in 18 subjects for knee pain treatment. All subjects had both an 
in person assessment and a remote telerehabilitation assessment. The authors reported that there was a 
high level of agreement between diagnoses based on in-person assessment and remote telerehabilitation 
assessment. The study enrolled persons with a mean age of 23 years which resulted in a high prevalence 
of acute and subacute conditions relative to chronic conditions which limits the generalizability of the 
findings to middle-aged and older adults who are more likely to have chronic conditions, such as 
osteoarthritis.  
Health outcomes 
The authors of the systematic review included in CHBRP’s literature review for the SB 289 report found 
that the studies they included in their review reported that clinical outcomes experienced by persons who 
received telerehabilitation were as good or better than outcomes of treatments to which telerehabilitation 
was compared (Kairy et al., 2009). 
The findings for health outcomes for telerehabilitation are based on two systematic reviews and meta-
analyses (Shukla et al., 2016; Tchero et al., 2018). Tchero et al. examined the effectiveness of multiple 
modalities of telerehabilitation on stroke survivor patients compared to standard rehabilitation or home-
based exercise programs.  Modalities included video-based therapy programs, remote patient monitoring, 
telephone calls and videoconferencing with providers including physiotherapists, physical therapists, 
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occupational therapists, neurologists, or physicians. The systematic review included 15 RCTs (1,339 
patients), 12 of which were included in a meta-analysis (1,246 patients) The meta-analysis found no 
statistically significant differences for activities of daily living or motor function between the patients in the 
telerehabilitation and patients in the usual care groups (Tchero et al., 2018). 
Shukla examined the effectiveness of home telerehabilitation via videoconferencing compared to 
conventional rehabilitation among patients who underwent total knee arthroscopy (Shukla et al., 2016: 6 
studies; 408 patients). There were no statistically significant differences in change for active knee 
extension and flexion, physical activity, or functional status in the home telerehabilitation group compared 
to the conventional rehabilitation group.   
Summary of findings regarding the effectiveness of telerehabilitation services:  CHBRP concludes 
that there is inconclusive evidence to determine whether services provided by telerehabilitation are as 
effective as medical care provided in person for access to care.   
There is insufficient evidence to determine whether services provided by telerehabilitation are as effective 
as medical care provided in person for processes of care. CHBRP notes that the absence of evidence 
does not mean there is no effect; it means the effect is unknown. 
There is a preponderance of evidence that telerehabilitation is effective in improving health outcomes 
such as activities of daily living, motor function, and physical activity based on two meta-analyses of 21 
studies .  
Figure 6. Effectiveness of Health Services Delivered by Telerehabilitation on Health Outcomes 
 
Findings for Electronic Consultation (eConsult) 
Access to care and utilization 
CHBRP found three systematic reviews and seven observational studies that addressed the effects of 
eConsult on access to care and utilization across multiple specialties, including otolaryngology-head and 
neck surgery, rheumatology, dermatology, orthopedics, and psychiatry (Archibald et al., 2018; Kohlert et 
al., 2018; Lai et al., 2018; Liddy et al., 2019, 2018, 2019; Lowenstein et al., 2017; Naka et al.,2018; 
Rostom et al.,2018; Vimalananda et al., 2015). The studies consistently found that e-consultation was 
associated with shorter time to treatment, shorter wait time for specialist input, and fewer avoidable 
specialist visits.  
One systematic review (27 studies: 22 research studies, 5 system descriptions) reported that the time 
between placing a referral and specialist input was shorter with e-consults than with traditional referrals 
(Vimalananda et al., 2015). In this review, Vimalananda et al. (2015) reported E-consultation time was 
most commonly reported as less than 3 days (3 studies). Liddy el al. (2018) reported that the 
average/median time for the PCPs to receive a response from the specialists to the eConsult requests 
ranged from <1 to <6 days (5 studies). A previous systematic review by Liddy el al. (2019) also found that 
eConsults were associated with short response times (4.6 hours to 3.9 days). Many of the studies 
included in the systematic reviews were conducted at San Francisco General Hospital, the Mayo Clinic, 
and Department of Veterans Affairs medical centers.  
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In a case study of eConsults conducted at the University of California, San Francisco, Lowenstein et al. 
(2017) performed a content analysis of the first 50 eConsults to psychiatry after the program was 
implemented. The authors found that the psychiatrists were able to address all requested eConsults with 
an average response time of 1.4 days. The primary care physicians implemented the treatment 
recommendations provided by the psychiatrist in 76% of consults and the majority of eConsults. The 
majority of consultations (74%) concerned management of medications used to treat mental health 
conditions. 
Five individual studies of eConsults provided through the Champlain Building Access to Specialists 
through eConsultation system in Ontario, Canada, have been published since the studies included in this 
systematic review. In a study of eConsults in an otolaryngology-head and neck surgery practice, Kohlert 
et al. ( 2018) reported the median response time was nearly 29 times faster than traditional in-person 
consultation, with over 40% of eConsults receiving a response within 24 hours and nearly all eConsults 
answered within 7 calendar days. In a cross-sectional study of eConsult cases in a multispecialty practice 
(n = 14,105), Liddy et al. (2018) reported a median response time of 21 hours.  Similarly, in a pediatric 
specialty referral system, Lai et al. (2018) found median specialist response time was 0.9 days (range <1 
hour to 27 days). Rostom et al. (2018) reported that the median response time by the rheumatologists 
was 1.9 days. Archibald et al. (2018) reported the average response time for eConsults with psychiatrists 
was 2.3 days and that the electronic consults took less than 15 minutes on average for the psychiatrist to 
complete. The PCPs participating in this study noted that the response time for eConsults was much 
shorter than for traditional referrals.  
Liddy et al. (2018) reported that the average time for specialists to respond to eConsult requests sent by 
PCPs ranged from 1 to 6 days (3 studies) compared to typical wait times for an in-person visit with a 
specialist, which is usually 4 weeks in Canada. Another study in Canada found patient wait time was 
significantly shorter for an eConsult referral (1 day, 95% confidence interval [CI]: 0.9 to 1.2 days) 
compared with a referral for an in-person visit (132 days; 95% CI: 127 to 136 days) (Lai et al., 2018). In a 
retrospective cohort study of 2,385 dermatology referrals in a medically underserved community health 
center in the United States, Naka et al. (2018) found that before implementation of eConsults, 11% of 
1,258 referrals resulted in a confirmed appointment with a median wait time of 77 days. After 
implementation, 49% of 1,127 consults received a diagnosis or treatment plan within 1 day on average. 
Of those, 16% required an in-person visit, with a median wait time of 28 days.  
Studies have found eConsult allows primary care physicians to manage patients who may otherwise need 
a specialist visit (Liddy et al., 2019; Vimalananda et al., 2015). The studies that Vimalananda and 
colleagues included in their systematic review found that specialists reported fewer inappropriate visits, 
fewer avoidable follow-up visits, and more eConsult based follow-up visits versus paper-based referrals. 
The authors noted the greatest impact for hematology, endocrinology, and dermatology, with one study 
reporting that over 50% of in-person  specialty visits were avoided through the use of e-consult (1 study; 
406 e-consultations) (Vimalananda et al., 2015). Liddy et al. (2019) systematic review reported reductions 
in the numbers of patients referred for in-person visits with specialists (12–84%). Another systematic 
review (Liddy et al., 2019: 43 studies) found most studies (30 of 43 studies) reported between 7.4% and 
78% reductions in the number of in-person specialist visits. Lowenstein et al. (2017) found that in 74% of 
eConsults, psychiatrists recommended that the primary care physician continue to manage the patient 
without referral for an in-person psychiatry visit. Three individual studies of eConsults provided through 
the Champlain Building Access to Specialists through eConsult system that were published after the 
literature searches for the systematic reviews addressed the impact of eConsults on referrals to 
otolaryngologists for in-person care. Kohlert et al. (2018) reported unnecessary referrals to specialists for 
in-person visits were avoided in 33.4% of all eConsults. Liddy et al. (2018) reported that 65% of all 
eConsults were resolved without a specialist in-person visit and Archibald et al. (2018) reported that 
30.7% of the eConsults eliminated the need for a patient referral to a psychiatrist.  
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Process of care 
CHBRP did not identify any studies of the impact of eConsults on processes of care.  
Health outcomes 
CHBRP did not identify any studies of the impact of eConsults on health outcomes. One explanation for 
this finding may be a lack of consistency in how eConsults are distinguished from other telehealth 
modalities. One systematic review on eConsults (Liddy et al., 2019) included three RCTs on store-and-
forward dermatology consults that CHBRP identified and discussed in the subsection of the Medical 
Effectiveness section that concerns store-and-forward. 
Summary of findings regarding the effectiveness of health services delivered by e-consultation: 
There is preponderance of evidence based on two systematic review and 5 studies that services 
delivered by eConsults reduce the time that patients and primary care providers wait to obtain specialists’ 
input and can substitute for a substantial proportion of in-person visits to specialists. There is insufficient 
evidence to determine whether eConsults improve processes of care and health outcomes. CHBRP notes 
that absence of evidence is not evidence of no effect. 
Figure 7. Effectiveness of Health Services Delivered by eConsult on Access to Care and Utilization 
 
 
Findings for Remote Patient Monitoring 
The findings for remote patient monitoring are based on a large AHRQ review of systematic reviews 
(Totten et al., 2016: 58 systematic reviews) specifically addressing remote patient monitoring (17 
systematics review studies; 202 studies; 48,321 patients). The systematic reviews identified by ARHQ 
includes both RCTs and observational studies.  
Access to care and utilization 
The AHRQ review of systematic reviews identified four systematic reviews regarding remote patient 
monitoring for heart failure. Two of the four systematics reviews (41 RCTs) reported that remote 
monitoring was associated with fewer heart failure-related hospitalizations  and one systematic review 
reported fewer heart failure related hospital admissions (6 of 9 RCTs reported this outcome). Two 
systematic reviews of people with chronic obstructive pulmonary disease (COPD) found that use of 
remote patient monitoring was associated with fewer hospitalization and fewer emergency department 
visits. One systematic review (18 RCTs; 34 total studies included) found that, while patients with mixed 
chronic conditions reported significantly more primary care and specialty care physician office visits, they 
also reported fewer hospitalizations and fewer emergency department visits (Totten et al., 2016).  
Process of care 
CHBRP found no studies on the effects of remote patient monitoring on processes of care. 
Analysis of California Assembly Bill 744 
Current as of April 16, 2019 www.chbrp.org 29 
Health outcomes 
Two systematic reviews included in the AHRQ report found remote patient monitoring was associated 
with improvements in quality of life (2 RCTs) and no difference in mortality (8 RCTs) for patients with 
COPD who received remote monitoring.  Of four systematic review studies examining remote patient 
monitoring for heart failure, 3 systematic reviews found that remote monitoring was associated with lower 
mortality (included 50 RCTs). One systematic review (9 RCTs) examining patients with implanted 
cardioverter-defibrillators found a reduction in odds of all-cause mortality (3 RCTs) and inappropriate 
receipt of shock. One systematics review (6 RCTs) found remote patient monitoring significantly improved 
HgA1c in patients with diabetes. 
The AHRQ report found that studies of patients with mixed chronic conditions (49 studies; 33 RCTs) 
found remote patient monitoring was associated with improvements in clinical outcomes (5 RCTs), 
symptoms (5 RCTs), and psychosocial outcomes (5 RCTs) (Totten et al., 2016).  
Summary of findings regarding the effectiveness of health services delivered by remote patient 
monitoring: There is clear and convincing evidence based on a large systematic review that services 
delivered by remote patient monitoring reduce utilization of emergency departments and hospitals and 
improve health outcomes.    
There is insufficient evidence that services delivered by remote patient monitoring improves processes of 
care. 
Figure 8. Effectiveness of Health Services Delivered by Remote Patient Monitoring on Access to Care 
and Utilization and Health Outcomes 
 
 
Potential Harms of Telehealth 
CHBRP found that potential harms frequently mentioned in the telehealth literature included further 
fragmentation of care (especially when patients access out-of-network providers); misdiagnosis (which 
varies greatly with technology type and disease condition) (Heinzelmann et al., 2005; Kassirer, 2000); 
inappropriate antibiotic prescribing (Ray et al., 2019); and potential delays of immediate care seeking in 
the emergency department, which could pose a significant safety risk for patients with urgent or emergent 
conditions (Hall and McGraw, 2014; Lewis et al., 2005; Nelson and Staggers, 2014). Other potential 
harms associated with e-mail care included those associated with provider lack of adherence to security 
protocol, informed consent, breaches in patient privacy, and unauthorized access to and/or use of patient 
health care information (Burke and Hall, 2015; Hall and McGraw, 2014; Menachemi et al., 2011). These 
harms can be mitigated if providers and patients use email through a secure web portal. 
The American Heart Association finds that the advantages of telehealth outweigh concerns about patient 
privacy, data accuracy, ease of use, and lack of technical infrastructure in rural communities and provides 
suggestions for ameliorating these challenges (Schwamm et al., 2017). 
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Summary of Findings Table 
Table 5 summarizes evidence of the effectiveness of telehealth for access and utilization; processes of 
care; and health outcomes. Findings are reported separately for each telehealth modality because 
findings differ across these types of uses. Evidence is also reported separately for the three types of 
outcomes because the strength of evidence of the effectiveness of telehealth modalities varies across the 
outcomes.  
Table 5. Summary of Evidence of Medical Effectiveness of Telehealth 
 Access and Utilization Processes of Care Health Outcomes 
Live video Preponderance of evidence – effective 
Clear and convincing 
evidence – effective 
Clear and convincing 
evidence – effective  
Store and forward Preponderance of evidence – effective 
Inconclusive 
evidence 
Limited evidence –
effective 
E-mail, synchronous text, 
and chat conferencing Inconclusive evidence 
Limited evidence –
effective 
Limited evidence –
effective 
Telephone Inconclusive evidence Limited evidence –effective 
Preponderance of 
evidence – effective 
Telestroke  Insufficient evidence Preponderance of evidence – effective 
Preponderance of 
evidence – effective 
Telerehabilitation Inconclusive evidence Insufficient evidence Preponderance of evidence – effective 
eConsult Preponderance of evidence – effective Insufficient evidence Insufficient evidence 
Remote patient monitoring Clear and convincing evidence – effective Insufficient evidence 
Clear and convincing 
evidence – effective 
Source: California Health Benefits Review Program, 2019.  
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BENEFIT COVERAGE, UTILIZATION, AND COST IMPACTS 
As discussed in the Policy Context section, AB 744 would require DMHC-regulated health plans, 
including Medi-Cal Managed Care plans, and CDI-regulated policies to reimburse providers for telehealth 
services at the same rate as equivalent in-person services.  
This section reports the potential incremental impacts of AB 744 on estimated baseline benefit coverage, 
utilization, and overall cost.  
CHBRP limits analysis of AB 744 to telehealth services provided by a physician or billable non-physician 
provider to patients that are considered equivalent to in person services, and delivered via 
videoconferencing, e-mail, or synchronous text/chat, telephone, and store and forward. As described in 
the Medical Effectiveness section, certain services could be delivered through a variety of these 
modalities. CHBRP analyzed CPT billing claims associated with services traditionally delivered to patients 
on an in-person basis that could potentially be delivered electronically via the methods named above. 
CHBRP specifically excluded eConsults and remote patient monitoring from the Benefit Coverage, 
Utilization, and Cost Impacts analysis because of data limitations and challenges in billing for those 
services by providers due to capacity and technology, which AB 744 does not propose to alter. However, 
the Long-Term Impacts section discusses the new Medicare payment policy and coding practices that 
went into effect on January 1, 2019 that could alter billing practices and facilitate use of telehealth 
services in the future. 
CHBRP examined the literature to obtain estimates for:  
• Adopting, or initiating, use of telehealth by providers and patients;  
• The impact of use of these technologies on in-person visits (i.e., how much does telehealth serve 
as a substitute for in-person care); 
• Impact on supplementary visits (i.e., how much does telehealth generate additional visits or other 
contacts that provided “added value” to patients’ care that would not have occurred or have been 
billed because telehealth was not covered or reimbursed); and, 
• Impact on cost sharing and impact on long-term use and health (beyond the 1-year horizon in the 
cost analysis).  
Telehealth is considered a component of broader health care utilization that can be helpful in managing 
disease and health, and several modalities appear to be equivalent to in-person services in terms of 
access to care and utilization, process of care, and health outcomes. As depicted in the Medical 
Effectiveness section (see Table 5), the literature on the medical effectiveness impacts of telehealth 
modalities indicates that live videoconferencing, store-and-forward, and telestroke are at least as effective 
as in-person care for some outcomes. Despite evidence that live videoconferencing was equivalent to in-
person services, the evidence does not suggest any impact on hospitalization rates, emergency 
department visits, outpatient specialty visits, or outpatient primary care visits. Additional published 
evidence suggests that new use of telehealth services through methods such as videoconferencing, 
telephone, e-mail, or synchronous text/chat do not replace the need for office visits, but instead act as 
supplemental services to address patient health needs (Pearl, 2014; Shah et al., 2018).  
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Assumptions on Utilization and Cost 
CHBRP assumes insurance carriers would not realize cost savings resulting from either new telehealth 
services, or telehealth services that substitute for in-person visits because:  
• Providers would receive reimbursement for telehealth visits equal to reimbursement for 
comparable in-person visits (according to AB 744 bill language); and 
• Requirements that telehealth visits have to be equivalent to in-person visits (per bill language and 
CPT code definitions) mean that providers are likely to dedicate similar levels of resources and 
capacity to deliver the same type of visit, whether delivered via in-person or telehealth modality. 
CHBRP anticipates a shift in the service delivery settings from in-person to telehealth visits post-mandate. 
That means telehealth services will represent a larger share of overall health services use post-mandate. 
The core assumptions that CHBRP made in understanding the impact on utilization and costs are: 
• If AB 744 is enacted, CHBRP assumes physicians and billable non-physician providers would be 
more likely to bill for services delivered via telehealth modalities that: 
o Substitute (or replace) current (1) in-person visits with live videoconference, store-and-
forward, telephone, e-mail and synchronous text/chat for encounters, and (2) telehealth visits 
that were billed without modifiers or location information so that they appeared to be in-
person visits when examining claims data; and 
o Supplement current in-person visits with added services via telehealth, and include both 
services that: (1) would previously not have been delivered in person due to distance, 
inconvenience, and time; and (2) services that physicians have already been providing via 
telephone, e-mail, and other electronic methods but were previously not billed or reimbursed 
because they were not covered or there were barriers to reimbursement.16 CHBRP’s analysis 
constrains coverage of services to those that are physician or billable non-physician-provided 
only; CHBRP assumes that the capacity to add supplemental services is constrained due to 
each billable provider’s capacity (including their staff’s ability to deliver and bill for services 
ordered by the physician) and technology available to the provider and/or patient. 
• CHBRP assumes that current billing practice for live video, store and forward, telephone, e-mail, 
and synchronous text/chat modalities underestimates true utilization of these services because 
the majority of enrollees subject to AB 744 already have coverage for these settings or services 
at equivalent payment to equivalent  in-person services (see Table 1), and there are barriers to 
utilization, billing limits, and other factors that result in a lack of information showing up in claims 
data, (Medicare Payment Advisory Commission (MedPAC), 2018). If AB 744 officially codifies 
and standardizes telehealth billing standards and price equivalence to in-person visits, CHBRP 
anticipates that claims will begin appearing for telehealth reflecting newly paid claims (both 
supplemental and substitute). 
• CHBRP assumes that certain telehealth services provided by third-party telehealth vendors for 
enrollees in partnership with insurance carriers (e.g., Teladoc, etc.) where the enrollee pays a fee 
for a virtual visit are not considered billable under current state law. According to the CHBRP 
carrier surveys, 10% of commercial insurance enrollees and 17% of Medi-Cal enrollees have 
access to these third-party services. CHBRP assumes that postmandate, this type of encounter 
                                                     
16 Some telehealth services will still not be reimbursed due to CPT coding standards related to follow-up visits within 
7 days for the same issue, regardless of setting. However, the supplementary services are assumed to meet coding 
rules and be billable. 
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will remain ineligible for reimbursement because the encounter may be with a non-billable 
provider (e.g., because non-billable providers tend to deliver these types of services or billable 
providers of a national vendor may not be licensed by California’s Business and Professions 
code). For this reason, some of the new supplementary services will offset these provided 
services that have not resulted in claims to insurers themselves. CHBRP has no data on current 
use of these third-party telehealth services and would count “new” services replacing third-party 
vendor-provided services as supplemental because they would incur new claims that have not 
been observed in current billing practices.  
• In some cases, insurers contract with a telehealth service (i.e., Teladoc, or HealthNet’s MD Live) 
to provide nurse triage, virtual visits, and other services without a copayment or cost to the 
enrollee. These services do not appear to be directly billing insurance carriers through claims, 
and they may have another per-call or subscription-based model with the insurer. These services 
do not satisfy compliance with AB 744, which would require health insurers to provide 
reimbursement to providers outside of these third-party arrangements for telehealth services. 
• CHBRP assumes that additional increases in telehealth services with the introduction of AB 744 
would not occur for Kaiser Permanente because of their existing telehealth infrastructure, closed 
HMO model, and established telehealth processes and coverage policies. For plans that contract 
with external physician groups, CHBRP assumed utilization of telehealth services would increase. 
The incentives for use of telehealth will differ among plans because of the contracting 
mechanisms used by each plan with their network providers. CHBRP recognizes that capitation 
rates for specific physician groups might not increase immediately to reflect any anticipated 
increase in the total cost to provide physician services. However, to the extent CHBRP assumes 
an increase in the utilization of telehealth services, and, in particular, supplemental telehealth 
services, it will be reflected in estimated premiums for 2020 and 2021 (see Table 1 and Table 10). 
• CHBRP assumes that the likelihood of fraud occurring in telehealth is equivalent to that in 
reimbursement for in-person services. There is existing evidence that inappropriate billing for in-
person services is occurring so that providers can be paid for telehealth services delivered (GAO, 
2017). AB 744 should address this issue, but there is no reason to believe that fraud will be more 
prevalent in telehealth than in in-person care due to improved benefit coverage and the 
reimbursement parity requirement. 
Additional Considerations Used to Develop Estimates of Utilization and Cost 
• CHBRP estimates that enrollees would pay a copayment or coinsurance amount equivalent to 
comparable in-person services (on average, 20% of the per unit cost) for telehealth visits, as 
permitted under AB 744. CHBRP believes cost-sharing scenarios are more likely than no cost 
sharing once telehealth becomes widely reimbursable, based upon the carrier’s responses 
related to coverage and cost sharing. AB 744 explicitly allows cost-sharing equivalent or less than 
cost-sharing for in-person visits.  
• CHBRP used data from a recent publication on telehealth use among physicians to estimate the 
amount of new telehealth services that could be delivered in the first 2-years of implementation 
(2020-2021) due to AB 744. CHBRP estimated that the adoption of telehealth that would support 
new use of supplemental and substitute services would be limited based on recent survey data 
analysis that determined only 15.4% of physicians worked in practices that used telehealth for a 
wide variety of visits, including store and forward of radiology findings. The same article found 
that use of telehealth to support communication between physicians and other health care 
professionals was even lower, at 11.2% (Kane and Gillis, 2018). Based on carrier survey 
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responses suggesting that telehealth is already a covered benefit and paid at parity with 
equivalent in-person services, CHBRP estimates that telehealth capacity and delivery would not 
become widespread and universally available across providers immediately, given the published 
evidence about its use. Due to this combination of limited existing capacity for telehealth in the 
provider community and the relatively high level of coverage for telehealth services reported by 
insurance carriers, CHBRP assumed that the response to telehealth would be dampened in 
Years 1 and 2 as described below. 
• Because existing claims data are an unreliable source of current utilization rates of telehealth 
services, CHBRP used information from Kaiser Permanente Northern California (KPNC) to 
estimate utilization because the KPNC experience is the only well-documented examination of 
utilization of telehealth visits between physicians and patients for the California region. The 
evaluation occurred over the period of time between 2008 (at the introduction of a telehealth 
strategy that included phone, secure e-mail, and live videoconference visits) and 2013, (Pearl, 
2014). KPNC’s experience indicates about 22.8% of all services that have an associated 
telehealth modality are provided via telehealth. However, we recognize that KPNC’s utilization 
rates are likely to be higher than average because KPNC has been pushing the adoption of 
telehealth for many years and can do so more seamlessly than other health plans and insurers, 
given that it is an integrated delivery system and their providers have telehealth capabilities built 
into their workflows. Therefore, CHBRP applies a dampening factor of 75% (meaning that 
CHBRP expects 25% of the impact experiences by KPNC). At baseline, the population with 
coverage is estimated to have a 5.7% utilization rate among all visits in Year 1. The population 
without coverage is assumed to have 0% utilization rate at baseline. Postmandate, the population 
without coverage is estimated to experience increased utilization to match the utilization rate of 
those with coverage. For the second year, we also relied on KPNC experience indicating about 
26.1% of all services that have an associated telehealth modality are provided via telehealth. 
After applying the dampening factor, the utilization rate for those with coverage is expected to be 
6.54% for Year 2.  
• CHBRP estimates that substitute services constitute 29% of all new outpatient telehealth services 
(i.e., replacing in-person services of comparable severity and time), whereas supplementary 
outpatient telehealth services would constitute 71% (i.e., additional services that were previously 
provided but not reimbursed, or not previously provided). This assumption is partially based upon 
the fact that reimbursement parity between telehealth and in-person services would provide 
incentives for providers to deliver care via telehealth as the reimbursement is equivalent and the 
administrative or time burden may be the same or better under telehealth. It is supported by a 
recent publication that examined the share of new telehealth services in comparison to in person 
services delivered in an Accountable Care Organization (Shah et al., 2018). Other published 
articles that focused on narrower types of service use support the conclusion that supplemental 
(i.e. new) services will outweigh substitute services when telehealth access is expanded 
(Ashwood et al., 2017; Bavafa et al., 2018; MedPAC, 2018; Mehrotra et al., 2017). 
• CHBRP estimates that certain services, such as radiology, pathology, laboratory, ICU, or stroke 
care delivered via telehealth will be a direct substitute for the equivalent in-person service and will 
not result in additional supplemental services as described above. In the case of serious 
conditions like stroke, care will need to be delivered via telehealth or in-person options during a 
short time-period, limiting the ability for additional supplemental services to be provided.  
• Evidence suggests that most physicians do not have the same level of telehealth technology as a 
large staff model HMO like Kaiser Permanente in their practices, especially in smaller settings 
(Kane and Gillis, 2018). The relatively lower rates of outpatient telehealth use in years 1 and 2 in 
comparison to Kaiser Permanente’s experience (Pearl, 2014) are supported by another study 
Analysis of California Assembly Bill 744 
Current as of April 16, 2019 www.chbrp.org 35 
suggesting that telehealth use increased by 6% 1 year after implementation (Bavafa et al., 2018). 
Exclusions include visits related to anesthesia and surgery, which are predominantly delivered in-
person.  
• As discussed in the Policy Context section, there is evidence from the Government Accountability 
Office (GAO) suggests that telehealth services are already being delivered and inappropriately 
billed as in-person visits due to constraints on coverage, originating site locations, lack of 
knowledge by billing managers, and other barriers to obtaining reimbursement, (GAO, 2017). 
Limited Evidence on Telehealth Use and Adoption 
Kaiser Permanente’s experience in Northern California could overestimate the use of a fully implemented 
system for telephone and e-mail. However, KPNC’s evidence on use of telephone and e-mail is the best 
estimate available for the initial and future adoption of the modalities by providers and patients, once a 
carrier develops the capacity and pays for telephone and e-mail services.  
• First, at Kaiser Permanente, telephone, e-mail, and live videoconference services are already 
delivered as part of an integrated system where fee-for-service reimbursement does not occur. 
Enrollees do not pay any cost sharing for telephone or e-mail visits. Although the Kaiser 
Permanente rate of telephone and e-mail use serves as a good benchmark, the first and second 
year (2020 and 2021) impact of AB 744 will be limited because outside of a closed, integrated, 
salary-based system, use of telehealth may be lower due to insurers and physicians requiring 
cost sharing which could dampen demand.  
• Kaiser Permanente may realize savings and efficiencies from the creation and widespread use of 
telehealth to reduce in-person patient visits and to deliver care to enrollees in outlying areas who 
face access barriers due to transportation, disability, or work hours. Because of those incentives 
to deliver more efficient care Kaiser Permanente physicians may encourage telephone and e-mail 
use at a higher rate than other health insurance carriers. Conversely, health insurance carriers 
may decide that coverage of all telehealth modalities would allow them to expand the network of 
physicians available, deliver more timely care, and meet patient needs in a more efficient way to 
attract enrollees and cover a wider area.  
Based on these limitations, CHBRP made adjustments to apply Kaiser’s experience with dampened 
growth in telehealth use postmandate for the remainder of the commercial insurance market, which is 
made up of capitated and fee-for-service reimbursement, and could include patient cost sharing unlike the 
Kaiser model for telehealth.  
 
For further details on the underlying data sources and methods used in this analysis, please see 
Appendix C. 
Baseline and Postmandate Benefit Coverage 
Current (baseline) coverage of telehealth was determined by a survey of the largest (by enrollment) 
providers of health insurance in California. Responses to this survey represent 71% of enrollees with 
private market health insurance that can be subject to state mandates and 45% of enrollees with Medi-
Cal managed care coverage subject to AB 744. 
The baseline coverage and payment parity for Commercial and Medi-Cal managed care across all 
modalities for telehealth services varied by type of service, with 56.1% of enrollees having coverage for 
primary care and urgent care visits delivered via telehealth and 80.3% of enrollees having coverage for 
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outpatient mental health and substance use disorder services via telehealth (Table 1). It should be noted 
that coverage for Medi-Cal managed care enrollees that is fully-compliant with AB 744 varies by type of 
service and ranges between 0% and 78%. Overall, the vast majority of enrollees have coverage for 
telehealth paid at parity with equivalent in-person services. 
Baseline and Postmandate Utilization 
Commercial (large group, small group, and individual market) and CalPERS enrollees, as well as a 
majority of Medi-Cal beneficiaries are enrolled in DMHC-regulated plans which would be subject to AB 
744. Additional commercial enrollees are enrolled in CDI-regulated policies, which would also be subject 
to AB 744. CHBRP uses analyses by Milliman on commercial claims and Medi-Cal managed care 
encounters to estimate current utilization of phone, e-mail or synchronous text/chat, live 
videoconferencing, and store-and-forward. 
Baseline telehealth costs and associated utilization for the private insurance market were based on 2016 
Milliman commercial claims and enrollment data for the state of California. The Medi-Cal telehealth costs 
and associated utilization were based upon Medi-Cal managed care encounter data for a subset of 
counties in the state, collected by Milliman. Commercial enrollees currently use the following amounts of 
telehealth modalities per 1,000 enrollees: 52.9 office visits for primary care and urgent care, 47.2 office 
visits for ophthalmology, dermatology, and other specialists, 30.5 office visits for mental health/substance 
use disorder (MH/SUD), and 12.7 emergency department visits, diagnostic services, and other services 
(Table 1). Medi-Cal managed care enrollees currently use the following amounts of telehealth modalities 
per 1,000 enrollees: No office visits for primary care and urgent care, 32.6 office visits for ophthalmology, 
dermatology, and other specialists, 7.6 office visits for MH/SUD, and 2.4 emergency department visits, 
diagnostic services, and other services (Table 1). 
Enrollees could be receiving treatment through multiple telehealth modalities within a 1-year period of 
time, and those modalities could shift with new technologies, changes in convenience, or availability of 
services. AB 744 would require all enrollees to have coverage for telehealth services at parity with 
equivalent in-person services. CHBRP expects an increase in the use of telehealth services due to those 
policy changes, though it will be primarily driven by new coverage because most plans that currently 
cover telehealth services reported already paying for telehealth services at parity with equivalent in-
person services at baseline.  
CHBRP estimates that telehealth service use will increase due to the added coverage and reimbursement 
parity required by AB 744. The increases are likely to occur in certain areas that are likely to substitute for 
certain in-person services (i.e. teleradiology, telestroke, teleICU, and lab/pathology) and/or supplement 
existing in-person services (i.e. office visits, telepsychiatry). 
Postmandate, CHBRP estimates that use of telehealth modalities per 1,000 commercial enrollees will be: 
65.1 office visits for primary care and urgent care, 58.0 office visits for ophthalmology, dermatology, and 
other specialists, 37.5 office visits for MH/SUD, and 15.6 emergency department visits, diagnostic 
services, and other services. CHBRP estimates that use of telehealth modalities per 1,000 Medi-Cal 
managed care enrollees will be: 51.6 office visits for primary care and urgent care, 70.8 office visits for 
ophthalmology, dermatology, and other specialists, 9.8 office visits for MH/SUD, and 41.2 emergency 
department visits, diagnostic services, and other services (Table 1). The increase in telehealth services 
postmandate seen in Table 1 is accompanied by a slight decrease in the use of in-person services. 
Estimated increases are larger in the Medi-Cal managed care enrollee population due to a lack of current 
coverage across all modalities at parity, along with the lack of cost-sharing requirements in Medi-Cal. 
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Baseline and Postmandate Per-Unit Cost 
Table 1 provides a baseline estimate of per unit cost for each type of telehealth service based upon 
Milliman analysis of current telehealth claims for commercial enrollees and Medi-Cal managed care 
enrollees. The actual unit cost of services would change postmandate for some services due to current 
differences in reimbursement for telehealth and in-person services. AB 744 requires reimbursement parity 
such that telehealth and equivalent in-person services would have the same per unit cost.  
At baseline, Milliman’s analysis of commercial claims found that office visits for primary or urgent care 
delivered via telehealth had a per unit cost of $57, in comparison to a $134 in-person unit cost. 
Postmandate, new and existing telehealth services covered by insurers would need to be reimbursed at 
the higher reimbursement rate equivalent to in-person visits, so that all telehealth office visit for primary 
and urgent care would be paid at the $134 unit cost (137% increase) for commercial insurers that 
currently covered telehealth services or added benefit coverage as a result of AB 744. Telehealth 
services not currently paid at parity with equivalent in-person services include office visits for primary and 
urgent care, ophthalmology, dermatology, other specialists, and outpatient mental health and substance 
use disorder (MH/SUD). To reach parity, commercial insurers would need to pay rates that are 42% to 
137% higher to be equivalent to in-person visits for the same services (see Table 1). Based on Milliman’s 
analysis, telehealth visits for emergency department services, diagnostic services (i.e. radiology, 
pathology, laboratory, etc.), and other services were already being paid at parity with in-person services. 
In the case of radiology and lab/pathology, the data available is insufficient to determine whether a claim 
is for a telehealth service (i.e. store-and-forward) or in-person service due to coding limitations. Milliman 
estimated zero change in per unit costs in those cases where insufficient data about delivery setting 
occurred (see Appendix C for more information). 
At baseline, Milliman’s analysis of Medi-Cal managed care encounters found that office visits for primary 
or urgent care were not covered according to the carrier survey responses. Postmandate, new telehealth 
services covered by Medi-Cal managed care plans would need to be reimbursed at a $37 per visit rate, 
which is equivalent to in-person visits. Telehealth services not currently paid at parity with equivalent in-
person services include office visits for ophthalmology, dermatology, and other specialists, and 
emergency department services, diagnostics (i.e. radiology, pathology, laboratory, etc.). To reach parity, 
Medi-Cal managed care plans would need to pay rates that are 15% to 30% higher to be equivalent to in-
person visits for the same services (see Table 1). Based on Milliman’s analysis, telehealth visits for 
outpatient MH/SUD were already being paid at parity with in-person services. Milliman estimated zero 
change in per unit costs in those cases where insufficient data about delivery setting occurred (see 
Appendix C for more information). 
Baseline and Postmandate Expenditures 
Table 7 and Table 8 present baseline and postmandate expenditures by market segment for DMHC-
regulated plans and CDI-regulated policies. The tables present per member per month (PMPM) 
premiums, enrollee expenses for both covered and noncovered benefits, and total expenditures 
(premiums as well as enrollee expenses).  
AB 744 would increase total net annual expenditures by $278,298,000 or 0.17% for enrollees with 
DMHC-regulated plans and CDI-regulated policies. This increase is primarily driven by increases of 
$132,415,000 (0.15%) in spending by private group employers, $22,526,000 (0.24%) in spending by 
enrollees with individually purchased Covered California policies and $42,201,000 (0.15%) in spending by 
Medi-Cal managed care plans.  
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This increase in total net annual expenditures is due to a $228,853,000 change in total premiums (0.16% 
increase in total health insurance premiums paid by employers, Medi-Cal, and enrollees for newly 
covered benefits), adjusted by an $49,446,000 (0.34%) increase in enrollee expenses for covered 
benefits. 
Premiums 
Changes in premiums as a result of AB 744 would vary by market segment. Note that such changes are 
related to the number of enrollees (see Table 1, Table 7, and Table 8), with health insurance that would 
be subject to AB 744. 
CDI-regulated individual market policies would experience the largest increase in premiums (0.26%) due 
to AB 744 in the commercial insurance market, whereas DMHC-regulated individual market plans would 
experience the next highest increase (0.22%). The large-group market would experience the smallest 
premium increases, with estimated increases for DMHC-regulated plans of 0.15% and CDI-regulated 
policies of 0.11%.  
Among publicly funded DMHC-regulated health plans, Medi-Cal managed care plans for the under 65 
population would see the largest increase (0.17%), whereas CalPERS HMO plans would experience less 
of an increase (0.16%), and Medi-Cal managed care plans for the over 65 population would experience 
the smallest increase (0.07%). 
Enrollee Expenses 
AB 744-related changes in enrollee expenses for covered benefits (employee share of premiums, 
deductibles, copays, etc.) and enrollee expenses for noncovered benefits would vary by market segment. 
Note that such changes are related to the number of enrollees (see Table 1, Table 7, and Table 8) with 
health insurance that would be subject to AB 744 that are expected to use the relevant telehealth services 
during the year after enactment. 
In the commercial market, CHBRP estimates that the CDI-regulated individual market will experience the 
highest increase in enrollee expenses ($0.35 per member per month), while the lowest increase in the 
commercial market is $0.22 per member per month for DMHC-regulated small group plans.  
In the publicly funded plans, CHBRP estimates that there will be no increase in enrollee expenses due to 
prohibition on premiums for most Medi-Cal managed care members and the cap on premiums for higher-
income Medi-Cal managed care enrollees (i.e. children in higher-income families). However, CalPERS 
HMO enrollees are estimated to experience a $0.25 per member per month increase in enrollee 
expenses. 
CHBRP estimates a $0 impact for noncovered benefits across all DMHC-regulated and CDI-regulated 
insurance policies and plans. 
Out-of-Pocket Spending for Covered and Noncovered Expenses 
When possible, CHBRP estimates the marginal impact of the bill on out-of-pocket spending for covered 
and noncovered expenses, defined as uncovered medical expenses paid by the enrollee as well as out-
of-pocket expenses (e.g., deductibles, copayments, and coinsurance) (Table 1). Due to new coverage, 
CHBRP estimates that total out-of-pocket expenses for enrollees with existing coverage baseline and 
those newly covered who use telehealth services would increase by $49,446,000,000 (0.34%) under the 
new mandate.  
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It is possible that some enrollees incurred expenses related to services for which coverage was denied or 
delivered through third-party vendors (i.e. Teladoc or MDLive!), but CHBRP cannot estimate the 
frequency with which such situations occur and so cannot offer a calculation of impact. CHBRP estimates 
a $0 impact for noncovered medical expenses. 
CHBRP projects a change in coinsurance amounts paid due to the increases in per unit costs to establish 
parity between telehealth services and their equivalent in-person services. In the case of telehealth 
services that are currently paid at a lower rate than equivalent in-person services (i.e. primary care and 
urgent care office visits, outpatient MH/SUD visits, etc.) the cost sharing amount related to that visit will 
increase as the reimbursement rate paid by insurers is increased to comply with AB 744. However, the 
share of the total cost that coinsurance represents will not increase, due to AB 744’s limitation on 
telehealth cost-sharing requirements exceeding in-person cost sharing rates. Due to those changes in 
coinsurance for telehealth services, CHBRP estimates that all CDI- and DMHC-regulated commercial 
enrollees in the individual, small group, and large group markets will experience an increase in cost-
sharing (Table 6).  
Table 6. Cost-Sharing Impact of AB 744 
  Large Group Small Group 
Individual CalPERS 
HMO 
% of people with cost-sharing impact from the 
mandate 100.0% 100.0% 100.0% 100.0% 
Avg annual cost-sharing impact of cost-sharing 
impacted members (a)  $2.98   $2.67  $2.99   $3.04  
Source: California Health Benefits Review Program, 2019. 
Notes: Medi-Cal Managed Care is excluded from the table because AB 744 will not result in additional cost sharing for enrollees. 
(a) Not including premium. 
Key: CalPERS  = California Public Employees’ Retirement System; HMO = Health Maintenance Organizations. 
Potential Cost Offsets or Savings in the First 12 Months After Enactment 
CHBRP does not project any cost offsets or savings in health care that would result because of the 
enactment of provisions in AB 744. There are specific services, including telestroke and teleICU that are 
likely to directly replace in-person equivalent services, but due to the reimbursement parity requirement 
there will not be direct cost savings. Insofar as outcomes improve due to services such as telestroke, 
there could be benefits to patients that do not result in direct cost savings to health plans. These types of 
benefits are detailed in the Public Health Impacts section. 
Postmandate Administrative Expenses and Other Expenses 
CHBRP estimates that the increase in administrative costs of DMHC-regulated plans and/or CDI-
regulated policies will remain proportional to the increase in premiums. CHBRP assumes that if health 
care costs increase as a result of increased utilization or changes in unit costs, there is a corresponding 
proportional increase in administrative costs. CHBRP assumes that the administrative cost portion of 
premiums is unchanged. All health plans and insurers include a component for administration and profit in 
their premiums. 
Other Considerations for Policymakers 
In addition to the impacts a bill may have on benefit coverage, utilization, and cost, related considerations 
for policymakers are discussed below. 
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Postmandate Changes in the Number of Uninsured Persons17 
Because the change in average premiums does not exceed 1% for any market segment (see Table 1, 
Table 7, and Table 8), CHBRP would expect no measurable change in the number of uninsured persons 
due to the enactment of AB 744. 
Changes in Public Program Enrollment 
CHBRP estimates that the mandate would produce no measurable impact on enrollment in publicly 
funded insurance programs due to the enactment of AB 744. 
How Lack of Benefit Coverage Results in Cost Shifts to Other Payers 
It is not anticipated that AB 744 results in cost shifts to other payers, as it focuses on the availability of 
reimbursement for telehealth services rather than additional new benefits. The office visits and other 
benefits covered by AB 744 are already covered as in-person services, and AB 744 adds a requirement 
for reimbursement of those services delivered at telehealth-related sites or via telehealth modalities.
                                                     
17 See also CHBRP’s Uninsured: Criteria and Methods for Estimating the Impact of Mandates on the Number of 
Individuals Who Become Uninsured in Response to Premium Increases (December 2015), available at 
http://chbrp.com/analysis_methodology/cost_impact_analysis.php.  
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Table 7. Baseline Per Member Per Month Premiums and Total Expenditures by Market Segment, California, 2020 
  DMHC-Regulated  CDI-Regulated    
  Privately Funded Plans 
(by Market) (a) 
 Publicly Funded Plans  Privately Funded Plans 
(by Market) (a) 
   
  Large 
Group 
Small 
Group 
Individual  CalPERS 
HMOs (b) 
MCMC 
(Under 65) 
(c) 
MCMC 
(65+) (c) 
 Large 
Group 
Small 
Group 
Individual   Total 
Enrollee counts               
 
Total enrollees in 
plans/policies 
subject to state 
mandates (d) 10,565,000 3,099,000 2,184,000   523,000 6,796,000 795,000   318,000 108,000 102,000 
  
24,490,000 
 
Total enrollees in 
plans/policies 
subject to AB 744 10,565,000 3,099,000 2,184,000   523,000 6,796,000 795,000   318,000 108,000 102,000 
  
24,490,000 
Premiums                          
 
Average portion 
of premium paid 
by employer $555.35 $341.99 $0.00   $493.71 $268.13 $694.55   $710.92 $462.84 $0.00   $118,029,198,000 
 
Average portion 
of premium paid 
by employee $39.66 $205.44 $437.39   $94.04 $0.00 $0.00   $250.37 $202.64 $475.67   $26,521,718,000 
 Total premium $595.01 $547.43 $437.39   $587.76 $268.13 $694.55   $961.29 $665.48 $475.67   $144,550,916,000 
Enrollee expenses                          
 
For covered 
benefits 
(deductibles, 
copays, etc.) $46.18 $121.03 $115.38   $48.33 $0.00 $0.00   $162.44 $186.84 $168.51   $14,750,880,000 
 
For noncovered 
benefits (e) $0.00 $0.00 $0.00   $0.00 $0.00 $0.00   $0.00 $0.00 $0.00   $0 
 
Total 
expenditures $641.19 $668.46 $552.77   $636.08 $268.13 $694.55   $1,123.73 $852.31 $644.18   $159,301,796,000 
 
Source: California Health Benefits Review Program, 2019. 
Notes: (a) Includes enrollees with grandfathered and nongrandfathered health insurance acquired outside or through Covered California (the state’s health insurance marketplace). 
(b) Approximately 56.17% of CalPERS enrollees in DMHC-regulated plans are state retirees, state employees, or their dependents.  
(c) Medi-Cal Managed Care Plan expenditures for members over 65 include those who are also Medicare beneficiaries. This population does not include enrollees in COHS. 
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(d) Enrollees in plans and policies regulated by DMHC or CDI aged 0 to 64 years as well as enrollees 65 years or older in employer-sponsored health insurance.  This group includes 
commercial enrollees (including those associated with Covered California or CalPERS) and Medi-Cal beneficiaries enrolled in DMHC-regulated plans.18  
(e) Includes only those expenses that are paid directly by enrollees or other sources to providers for services related to the mandated benefit that are not currently covered by 
insurance. This only includes those expenses that will be newly covered, postmandate. Other components of expenditures in this table include all health care services covered by 
insurance. 
Key: CalPERS HMOs = California Public Employees’ Retirement System Health Maintenance Organizations; CDI = California Department of Insurance; COHS = County Organized 
Health Systems; DMHC = Department of Managed Health Care; MCMC = Medi-Cal Managed Care. 
 
                                                     
18 For more detail, see Estimates of Sources of Health Insurance in California, available at  http://chbrp.com/analysis_methodology/cost_impact_analysis.php.   
Analysis of California Assembly Bill 744 
Current as of April 16, 2019 www.chbrp.org 43 
Table 8. Postmandate Per Member Per Month Premiums and Total Expenditures by Market Segment, California, 2020 
  DMHC-Regulated  CDI-Regulated   
  Privately Funded Plans 
(by Market) (a) 
 Publicly Funded Plans  Privately Funded Plans 
(by Market) (a) 
  
  Large 
Group 
Small 
Group 
Individual  CalPERS 
HMOs (b) 
MCMC 
(Under  
65) (c) 
MCMC 
(65+) (c) 
 Large 
Group 
Small 
Group 
Individual  Total 
Enrollee counts              
 
Total enrollees in 
plans/policies 
subject to state 
mandates (d) 10,565,000 3,099,000 2,184,000   523,000 6,796,000 795,000   318,000 108,000 102,000 
 
24,490,000 
 
Total enrollees in 
plans/policies 
subject to AB 744 10,565,000 3,099,000 2,184,000   523,000 6,796,000 795,000   318,000 108,000 102,000 
 
24,490,000 
Premiums                         
 
Average portion of 
premium paid by 
employer $0.8487 $0.5616 $0.0000   $0.7774 $0.4633 $0.4633   $0.7784 $0.7399 $0.0000  $179,496,000 
 
Average portion of 
premium paid by 
employee $0.0606 $0.3374 $0.9622   $0.1481 $0.0000 $0.0000   $0.2741 $0.3239 $1.2370  $49,357,000 
 Total premium $0.9093 $0.8990 $0.9622   $0.9255 $0.4633 $0.4633   $1.0526 $1.0638 $1.2370  $228,853,000 
Enrollee expenses                         
 
For covered 
benefits 
(deductibles, 
copays, etc.) $0.2469 $0.2200 $0.2440   $0.2537 $0.0000 $0.0000   $0.3077 $0.2859 $0.3511  $49,446,000 
 
For noncovered 
benefits (e) $0.0000 $0.0000 $0.0000   $0.0000 $0.0000 $0.0000   $0.0000 $0.0000 $0.0000  $0 
 
Total 
expenditures $1.1562 $1.1190 $1.2062   $1.1792 $0.4633 $0.4633   $1.3603 $1.3497 $1.5881  $278,299,000 
Percent change                    
 Premiums 0.1528% 0.1642% 0.2200%   0.1575% 0.1728% 0.0667%   0.1095% 0.1599% 0.2601%  0.1583% 
 
Total 
expenditures 0.1803% 0.1674% 0.2182%   0.1854% 0.1728% 0.0667%   0.1210% 0.1584% 0.2465%  0.1747% 
Source: California Health Benefits Review Program, 2019. 
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Notes: (a) Includes enrollees with grandfathered and nongrandfathered health insurance acquired outside or through Covered California (the state’s health insurance marketplace). 
(b) Approximately 56.17% of CalPERS enrollees in DMHC-regulated plans are state retirees, state employees, or their dependents.  
(c) Medi-Cal Managed Care Plan expenditures for members over 65 include those who are also Medicare beneficiaries. This population does not include enrollees in COHS. 
(d) Enrollees in plans and policies regulated by DMHC or CDI aged 0 to 64 years as well as enrollees 65 years or older in employer-sponsored health insurance.  This group includes 
commercial enrollees (including those associated with Covered California or CalPERS) and Medi-Cal beneficiaries enrolled in DMHC-regulated plans.19  
(e) Includes only those expenses that are paid directly by enrollees or other sources to providers for services related to the mandated benefit that are not currently covered by 
insurance. This only includes those expenses that will be newly covered, postmandate. Other components of expenditures in this table include all health care services covered by 
insurance. 
Key: CalPERS HMOs = California Public Employees’ Retirement System Health Maintenance Organizations; CDI = California Department of Insurance; COHS = County Organized 
Health Systems; DMHC = Department of Managed Health Care; MCMC = Medi-Cal Managed Care. 
 
 
                                                     
19 For more detail, see Estimates of Sources of Health Insurance in California, available at  http://chbrp.com/analysis_methodology/cost_impact_analysis.php.   
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PUBLIC HEALTH IMPACTS 
As discussed in the Policy Context section, AB 744 would require state-regulated health plans and 
policies to cover and reimburse providers for telehealth services at parity with equivalent in-person 
services, beginning in January 2020. It also prohibits limitations on settings in which telehealth takes 
place and prohibits insurers from exclusively limiting telehealth coverage to third-party telehealth vendors. 
CHBRP estimates that approximately 24.5 million (63%) Californians will have health insurance in 2020 
that would be subject to this state health insurance benefit mandate law.  
This section estimates the short-term20 public health impact of AB 744 on access to care, health 
outcomes, and social determinants of health (including disparities by geography and access to 
technology See the Long-Term Impacts section for a discussion of access to care beyond the first 12 
months of the bill implementation.  
Estimated Public Health Outcomes 
CHBRP focuses this analysis on six modalities: live videoconferencing; store and forward; e-
mail/text/chat; telephone; eConsults; and remote patient monitoring. CHBRP presents the findings for 
telestroke and telerehabilitation services separately because the literature only reports composite findings 
of multiple modalities used in each specialty). As presented in the Medical Effectiveness section, AB 744 
applies to telehealth services across many diseases and conditions. The telehealth literature generally 
focuses on a limited number of conditions (e.g., dermatology, neurology, psychiatry/psychology) and may 
not be generalizable to other conditions. Overall, CHBRP found:  
• Clear and convincing evidence that live videoconferencing was at least as effective as in-
person care for mental health services and dermatology; 
• Varying evidence across multiple conditions that store and forward is at least as effective as in-
person care in terms of access to care (preponderance), process of care (inconclusive), and 
health outcomes (limited);  
• Limited evidence that text/chat or e-mail is as effective as in-person care (with the exception of a 
preponderance of evidence of effectiveness for glycemic control in patients with diabetes who 
communicated via e-mail with their provider);  
• Varying evidence that care delivered via telephone is at least as effective as in-person care in 
terms of access to care (inconclusive), process of care (limited), and health outcomes 
(preponderance); 
• Preponderance of evidence that telestroke and telerehabilitation care results in health 
outcomes at least as effective as in-person care; 
• Preponderance of evidence that eConsults reduce wait time for specialist care, but insufficient 
evidence of equivalent or better health outcomes; and 
• Clear and convincing evidence that remote patient monitoring provides similar or improved 
health outcomes and reductions in ED visits and hospitalizations. 
• As presented in Table 1, CHBRP estimates that a majority of enrollees with insurance subject to 
AB 744 already have coverage for telehealth at parity with in-person visits. Of the 20% to 49% of 
                                                     
20 CHBRP defines short-term impacts as changes occurring within 12 months of bill implementation. 
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enrollees receiving new coverage for various services reimbursed at parity under AB 744, 
CHBRP estimates a marginal increase in services ranging from 3.0/1,000 for emergency 
department visits, diagnostic services and other services to 12.1/1,000 primary care/urgent care 
visits by commercial enrollees; and 2.2/1,000 for outpatient MH/SUD visits to 51.6/1,000 for 
primary care/urgent care visits by Medi-Cal managed care enrollees . About 29% of the marginal 
increase in telehealth utilization is attributable to substitution and 71% is attributable to 
supplemental visits (visits previously provided, but not reimbursed or not previously provided). In 
the first year postmandate, CHBRP estimates that telehealth visits would represent 5.7% of all 
visits for those newly covered enrollees; this would match the utilization rate of those enrollees 
already covered at baseline. 
Access to Care 
As discussed in the Medical Effectiveness section, live video, store and forward, eConsult, and remote 
patient monitoring modalities reduce delays in care (appointments, diagnoses, and surgery) for certain 
conditions. 
Wootton and colleagues (2011) performed a review of the teledermatology literature and found 20 studies 
(both U.S. and non-U.S.) that measured the percentage of avoided travel through telemedicine (n = 5,199 
subjects). About 43% of patients were able to avoid travel through the use of store and forward compared 
to usual care (p < 0.001). In the seven live videoconferencing and one hybrid telehealth studies, an 
average of 70% of the patients avoided travel compared to usual care (p = 0.014) (Wootton et al., 2011).  
Patient interest in telehealth is growing and for those patients who use telehealth to communicate with 
their providers, satisfaction with the quality of telehealth visits is high (see the Background section). 
Patients note convenience factors, such as reductions in travel time, time away from work, and its 
associated costs as beneficial. 
CHBRP estimates that, postmandate, patient access to care could improve through provider use of live 
video, store and forward, eConsults, and remote patient monitoring; however, there is limited or 
insufficient evidence of other modalities (e-mail, chat, texting, telephone) improving access to care. 
Therefore, the public health impact of AB 744 is unknown, although CHBRP anticipates that at least some 
patients would be able to obtain more timely specialty or primary care. Those patients would also 
experience reduced travel time and associated costs.  
Health Outcomes 
As previously mentioned, the scope of health conditions potentially affected by AB 744 is vast and 
evidence of effectiveness is limited to a handful of conditions, such as diabetes, mental health, neurology, 
and dermatology. Across all conditions reviewed, the strongest evidence of telehealth producing health 
outcomes equivalent to in-person visits was related to mental health, dermatology, stroke, and diabetes.  
Although the number of telehealth encounters would increase, the public health impact of AB 744 is 
unknown. CHBRP is unable to assess changes in public health outcomes due to vast differences in study 
quality and findings of effectiveness across health conditions and telehealth modalities. For areas where 
stronger evidence exists, such as live videoconferencing, telephone, and remote patient monitoring, and 
for certain specialty areas (e.g., mental health, dermatologic or diabetes care) enrollees could see 
equivalent or improved health outcomes as compared with in-person care.  
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Social Determinants of Health and Disparities 
CHBRP defines social determinants of health (SDoH) as conditions in which people are born, grow, live, 
work, learn, and age. These social determinants of health (e.g., economic factors, social factors, 
education, physical environment) are shaped by the distribution of money, power, and resources and 
impacted by policy (adapted from Healthy People 2020, 2015; CDC, 2014). These factors generally occur 
prior to or outside of the health care system and are highly correlated with downstream events such as 
avoidable illnesses and premature death. In the case of AB 744, key determinants that may be affected 
by the mandate include transportation, rural living, and socioeconomic characteristics (age, race/ethnicity, 
income, language).  
Disparities in Use of Telehealth  
Impact on patient travel and rural health disparities 
Patients must travel to obtain in-person health care services, which can be a burden especially for those 
who live in rural areas, have limited transportation options, or complex conditions that make travel 
difficult. As described in the Background section, differences in health status and health care access exist 
between urban and rural communities in California. Travel costs include both the direct costs of 
transportation and the indirect costs, such as lost productivity and income, and delays in treatment 
associated with the travel. For patients experiencing these types of barriers, CHBRP finds that telehealth 
may improve access from the patient’s perspective. Patients in both urban and rural areas who cannot 
take time away from work, have difficulty traveling, or have questions or health problems occurring after 
usual office hours may find the convenience of e-mail, phone, and live videoconferencing to be beneficial. 
Such convenience can help patients avoid traffic delays, public transportation barriers, and related 
transportation costs (such as transportation fares, tolls, parking).  
Reviews of the telehealth literature show evidence of benefits that telehealth services provide to 
medically-underserved rural communities such as improved access to ambulatory and specialty care. 
Additionally, research indicates reductions in costs related to rural provider or patient travel, unnecessary 
office visits, emergency department visits or hospitalizations; indirect benefits such as consults initiated by 
rural providers may reduce future telehealth consultation needs as they learn from specialists (Marcin et 
al., 2016;).  
For patients with vehicular challenges (and their caregivers), traveling from home in a rural location to an 
urban-based health facility for treatment can be a potential barrier. A study of the use of store-and-
forward telehealth in Alaska found that travel was avoided in one of five primary care visits and three of 
four specialist visits, saving over $14 million for 15,6000 patient encounters over 7 years (Ferguson, 
2008). A more recent study by Cota et al. (2017) measured the effects, over 5 years, of an email 
teleorthopedic program in a Quebec province that helped primary care physicians manage acute 
orthopedic injuries for rural communities. They reported that 731 (71%) of patients, who would have 
traveled to a metropolitan area for consultation, were treated locally and avoided $5,500/patient 
(Canadian dollars) in rural patient transportation costs (e.g., airfare for initial and follow-up visits).  
CHBRP estimates that, postmandate, travel costs and travel time would likely decrease for some urban 
and rural enrollees using newly covered telehealth services.  As a result, some enrollees with 
transportation challenges would have equivalent or better outcomes because they would no longer delay 
or avoid in-person visits because of telephonic or electronic communications with physicians; however, 
CHBRP is unable to quantify the exact impact due to the breadth of telehealth services and conditions 
covered by AB 744. 
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Impact on disparities in technology use across demographic groups  
There is limited evidence about disparities in use of technologies covered by AB 744 and outcomes 
related to them. Earlier research notes that the use of e-mail as a mode of patient–physician 
communication requires access to and familiarity with computers. Three observational studies considered 
use of telephone and electronic health care in California and found some disparities by age, 
race/ethnicity, income, and literacy. Technology users were generally younger, healthier, and lived in 
more affluent communities (Pearl, 2014; Uscher-Pines and Mehrotra, 2013). Whites were also more likely 
to use online services than other racial/ethnic groups (Pearl, 2014). Other studies considered access to 
and use of computers by various sociodemographic categories including age, gender, income, education 
level, race, ethnicity, disability, and geography and documented disparities in all categories (Baldassare 
et al., 2013; Gibbons, 2008). Specific to the use of e-mail for health care advice and treatment, CHBRP 
found that older persons, low-income persons, and minorities (African Americans, Hispanics) were less 
likely to be interested in or use e-mail to communicate with a physician (Baldassare et al., 2013; Dudas 
and Crocetti, 2013; Mitchell et al., 2014). They were also less likely to have access to broadband Internet 
(Baldassare et al., 2013) and an e-mail account (Gibbons, 2008) (Table 3).  
Disparities in access to the internet and/or health status exist by age, income, race/ethnicity and rural 
areas (see the Background section), and to the extent that health care access for the rural population is 
improved through telehealth, AB 744 may help reduce disparities. However, the disparities gap could be 
expanded because telehealth communication tools are disproportionately unavailable to and accessed by 
those who are use only smart-phones (with limited data plans) or in areas lacking broadband service.  
It is unknown whether AB 744 would reduce disparities in access to care or health outcomes by 
ameliorating the effects of certain social determinants of health. As noted, transportation and geographic 
barriers to care could be reduced significantly for some by avoiding long drive times or difficult public 
transportation. However, AB 744 also could exacerbate disparities in access to care for those enrollees 
who have no broadband or smart phone (only) connectivity. 
Estimated Impact on Economic Loss 
CHBRP found little literature addressing the prevention of loss of productivity due to travel and in-person 
wait time. One employer with more than 20,000 employees offered a contracted, independent telehealth 
service and self-reported saving almost $800,000 in direct health costs and averted lost productivity 
(Zappe, 2012); however, no health outcomes were reported. In Alaska, store-and-forward telehealth 
decreased the time to see a specialist, leading to earlier diagnoses and treatments. In this case, the 
specialty consults were provided largely within the same working day (Ferguson, 2008).  
CHBRP estimates AB 744 would decrease lost productivity associated with travel to in-person visits; 
however, CHBRP is unable to quantify the effect due to the lack of data, and the breadth of telehealth 
modalities and health conditions covered by AB 744.  
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LONG-TERM IMPACTS 
In this section, CHBRP estimates the long-term impact21 of AB 744, which CHBRP defines as impacts 
occurring beyond the first 12 months after implementation. These estimates are qualitative and based on 
the existing evidence available in the literature. CHBRP does not provide quantitative estimates of long-
term impacts because of unknown improvements in clinical care, changes in prices, implementation of 
other complementary or conflicting policies, and other unexpected factors. 
Long-Term Utilization and Cost Impacts 
Utilization Impacts  
In Year 2 of implementation, AB 744 is expected to result in additional use of telehealth services (a 21% 
increase from the 5.7% share of telehealth out of all outpatient visits) such that telehealth represents 
6.54% of all visits. In addition, it is possible that as technology is integrated into physician practices and 
patients experience improved access to broadband, smart phones, and videoconferencing technology, 
the adoption by patients could also increase. Based on the experience at Kaiser Permanente Northern 
California (KPNC) (Pearl, 2014), telehealth services represented over half of all outpatient office visit 
equivalent services five years after the implementation of the online patient portal. In Kaiser 
Permanente’s experience from 2016 on, there is likely to be increased use of telehealth to conduct both 
substitute and supplementary health care visits. However, in the commercial insurance market outside of 
Kaiser, which uses networks that are not closed, integrated and staff-based, the adoption would be based 
upon patient preferences (because coinsurance would be identical to in-person visits), physician capacity 
(e.g., technology for secure e-mail and other electronic messaging, secure live videoconferencing, 
documentation, billing, and ability to collect copayments for remote telehealth visits), and patients’ access 
to broadband. Based on the Pearl (2014) study, CHBRP anticipates a commensurate increase due to 
access to telehealth created by AB 744. Once offered to enrollees, telehealth services would experience 
increases of more than 21% year-over-year according to the rate of growth reported by Pearl (2014). 
However, due to capacity constraints in medical groups, physician offices, and other facilities, CHBRP 
does not expect AB 744 to result in the widespread adoption of telehealth that occurred in KPNC due to 
the closed, integrated nature and alignment of incentives around telehealth that exists in the KPNC 
model. 
Although there has been a growth in third-party services (e.g., Teladoc, MDLive, etc.) providing 
telephonic physician consultation for between $0 and $60 that are not affected by AB 744, it is possible 
that these third-party services could continue to operate and be paid under AB 744 if they were able to 
adapt their model to become a billable, network provider for insurance carriers and plans by working with 
medical groups and ensuring their billable providers have California licenses. Currently, it appears they 
are contracted by or partnered with plans to provide a service to the patients, but it is not a covered 
benefit and the patients who use the service typically have to pay a share or all of the cost out-of-pocket 
for the virtual visit.  
Third-party telehealth services, which are not typically paid for by insurance, are likely to be more 
expensive to consumers than the cost sharing amount for a comparable telehealth service delivered 
through a billable provider and covered by an insurance plan or policy. Insurers may have an incentive to 
facilitate access to telehealth through these third-party vendors to avoid use of telehealth through billable 
providers with a higher per unit cost for services. However, patients are likely to use their own providers 
                                                     
21 See also CHBRP’s Criteria and Guidelines for the Analysis of Long-Term Impacts on Healthcare Costs and Public  
Health, available at http://www.chbrp.org/analysis_methodology/cost_impact_analysis.php.  
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for telehealth if given the option, and cost sharing amounts are likely to be more affordable than the costs 
of noncovered telehealth services delivered by third-party vendors (i.e., Teladoc, MDLive!). 
Cost Impacts 
In Year 2, CHBRP estimates that expenditures will result in a 0.1958% from baseline (an additional 
0.0211% from Year 1) due to increased adoption of telehealth by both providers and patients. See Table 
10 in Appendix C. 
If telehealth use expands as stated above, it is likely that increased spending on telehealth will occur. This 
is partially due to the new (i.e. supplemental services) telehealth services where the majority of growth will 
occur. Evidence suggests that the vast majority of telehealth services will not be substitutes, and there is 
no evidence that use of telehealth will reduce emergency department, inpatient hospitalization, primary 
care, or specialty visits in the long-term.  
Long-Term Public Health Impacts 
When possible, CHBRP estimates the long-term public health effects of a proposed mandate (beyond 
CHBRP’s 12-month analytic timeframe) to capture possible impacts to the public’s health that would be 
attributable to the mandate, including impacts on premature death and economic loss. CHBRP is unable 
to estimate the long-term impact of AB 744 on overall health outcomes and disparities due to the breadth 
of conditions telehealth affects and the unknown impact of future technology development. To the extent 
that advances in telehealth technology improve patient-initiated access and provider capacity, CHBRP 
projects some improvements in patient care (through a reduction in transportation barriers and/or more 
timely services). 
Access to Telehealth  
CHBRP assumes that technology will continue to drive adoption and integration of telehealth. In addition 
to increasing provider capacity as addressed in the Benefit Coverage, Cost and Utilization section, there 
are a variety of new technologies developed and adopted since CHBRP’s last telehealth report. Examples 
include a variety of remote patient monitoring modalities; increased penetration and advancement of 
electronic health records (EHR) and patient portals; increased remote patient monitoring devices, some of 
which may be integrated with EHR; and increased use of smartphones and tablets and their applications. 
Additionally, changes to broadband coverage through the success or failure of net neutrality laws will 
affect telehealth use. Finally, as the population ages, there may be an increased demand for these types 
of services from consumers, insurers, and providers due to comfort with and reliance on virtual 
communication. CHBRP projects that this trend, along with changes in CMS reimbursement policy in 
2019, and continued adoption of value-based, bundled care reimbursement models will likely increase 
use of e-mail, videoconferencing, and other telehealth services between patients and providers. However, 
assessing the impact of telehealth requires further study as large gaps in knowledge about health 
outcomes and health access disparities remain (Tuckson et al., 2017). 
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APPENDIX A  TEXT OF BILL ANALYZED 
On February 19, 2019, the California Assembly Committee on Health requested that CHBRP analyze AB 
744. 
 
ASSEMBLY BILL No. 744 
 
Introduced by Assembly Member Aguiar-Curry 
 
February 19, 2019 
 
An act to amend Section 2290.5 of the Business and Professions Code, to amend Section 
1374.13 of, and to add Sections 1341.46 and 1374.14 to, the Health and Safety Code, to amend 
Section 10123.85 of, and to add Section 10123.855 to, the Insurance Code, and to amend Section 
14132.725 of the Welfare and Institutions Code, relating to healthcare coverage. 
 
LEGISLATIVE COUNSEL'S DIGEST 
 
AB 744, as introduced, Aguiar-Curry. Healthcare coverage: telehealth. 
 
Existing law provides for the Medi-Cal program, which is administered by the State Department 
of Health Care Services, under which qualified low-income individuals receive healthcare 
services. The Medi-Cal program is, in part, governed and funded by federal Medicaid program 
provisions. Under existing law, face-to-face contact between a health care provider and a patient 
is not required under the Medi-Cal program for teleophthalmology, teledermatology, and 
teledentistry by store and forward. Existing law requires a Medi-Cal patient receiving 
teleophthalmology, teledermatology, or teledentistry by store and forward to be notified of the 
right to receive interactive communication with a distant specialist physician, optometrist, or 
dentist, and authorizes a patient to request that interactive communication. 
 
This bill would delete those interactive communication provisions. 
 
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure 
and regulation of health care service plans by the Department of Managed Health Care, and makes 
a willful violation of the act a crime. Existing law provides for the regulation of health insurers by 
the Department of Insurance. Existing law prohibits a health care service plan or health insurer 
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from requiring that in-person contact occur between a healthcare provider and a patient, and from 
limiting the type of setting where services are provided, before payment is made for covered 
services provided appropriately through telehealth services. 
 
This bill would require a contract issued, amended, or renewed on or after January 1, 2020, 
between a health care service plan and a healthcare provider for the provision of healthcare services 
to an enrollee or subscriber, or a contract issued, amended, or renewed on or after January 1, 2020, 
between a health insurer and a healthcare provider for an alternative rate of payment to specify 
that the health care service plan or health insurer reimburse a healthcare provider for the diagnosis, 
consultation, or treatment of an enrollee, subscriber, insured, or policyholder delivered through 
telehealth services on the same basis and to the same extent that the health care service plan or 
health insurer is responsible for reimbursement for the same service through in-person diagnosis, 
consultation, or treatment. The bill would authorize a health care service plan or health insurer to 
offer a contract or policy containing a deductible, copayment, or coinsurance requirement for a 
healthcare service delivered through telehealth services, subject to specified limitations. The bill 
would prohibit a health care service plan contract or policy or health insurance issued, amended, 
or renewed on or after January 1, 2020, from imposing an annual or lifetime dollar maximum for 
telehealth services, and would prohibit those contracts and policies from imposing a deductible, 
copayment, or coinsurance, or a plan year, calendar year, lifetime, or other durational benefit 
limitation or maximum for benefits or services that is not equally imposed on all terms and services 
covered under the contract. 
 
This bill would authorize the Director of the Department of Managed Health Care or the Insurance 
Commissioner to assess an administrative penalty by order, after appropriate notice and 
opportunity for hearing, if the director or commissioner determines that a health care service plan 
or health insurer has failed to comply with those provisions. The bill would create the Managed 
Care Penalty Account, within the Managed Care Administrative Fines and Penalties Fund, subject 
to appropriation by the Legislature, into which administrative penalties for a health care service 
plan’s violations of those provisions would be deposited. The bill would specify that administrative 
penalties assessed against a health insurer be deposited into the Insurance Fund. Because a willful 
violation of the bill’s requirements relative to health care service plans would be a crime, the bill 
would impose a state-mandated local program. 
 
The California Constitution requires the state to reimburse local agencies and school districts for 
certain costs mandated by the state. Statutory provisions establish procedures for making that 
reimbursement. 
 
This bill would provide that no reimbursement is required by this act for a specified reason. 
 
DIGEST KEY 
 
Vote: majority   Appropriation: no   Fiscal Committee: yes   Local Program: yes   
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BILL TEXT 
THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS: 
 
SECTION 1. 
Section 2290.5 of the Business and Professions Code is amended to read: 
 
2290.5 (a) For purposes of this division, the following definitions shall apply: 
(1)“Asynchronous store and forward” means the transmission of a patient’s medical information 
from an originating site to the health care provider at a distant site without the presence of the 
patient. 
(2) 
(1) “Distant site” means a site where a health care healthcare provider who provides health 
care healthcare services is located while providing these services via a telecommunications 
system. 
(3)“Health care 
 
(2) “Healthcare provider” means either of the following: 
 
(A) A person who is licensed under this division. 
 
(B) An associate marriage and family therapist or marriage and family therapist trainee functioning 
pursuant to Section 4980.43.3. 
 
(4) 
 
(3) “Originating site” means a site where a patient is located at the time health 
care healthcare services are provided via a telecommunications system or where 
the asynchronous store and forward service originates. 
 
(4) “Store and forward” means the transmission of a patient’s medical information from an 
originating site to the healthcare provider at a distant site. 
 
(5) “Synchronous interaction” means a real-time interaction between a patient and a health 
care healthcare provider located at a distant site. 
 
(6) “Telehealth” means the mode of delivering health care healthcare services and public health 
via information and communication technologies to facilitate the diagnosis, consultation, 
treatment, education, care management, and self-management of a patient’s health care while the 
patient is at the originating site and the health care provider is at a distant 
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site. healthcare. Telehealth facilitates patient self-management and caregiver support for patients 
and includes synchronous interactions and asynchronous store and forward transfers. 
(b) Prior to Before the delivery of health care healthcare via telehealth, the health 
care healthcare provider initiating the use of telehealth shall inform the patient about the use of 
telehealth and obtain verbal or written consent from the patient for the use of telehealth as an 
acceptable mode of delivering health care healthcare services and public health. The consent shall 
be documented. 
 
(c) Nothing in this section shall This section does not preclude a patient from receiving in-
person health care healthcare delivery services during a specified course of health 
care healthcare and treatment after agreeing to receive services via telehealth. 
 
(d) The failure of a health care healthcare provider to comply with this section shall constitute 
unprofessional conduct. Section 2314 shall not apply to this section. 
 
(e) This section shall not be construed to alter the scope of practice of any health 
care a healthcare provider or authorize the delivery of health care healthcareservices in a setting, 
or in a manner, not otherwise authorized by law. 
 
(f) All laws regarding the confidentiality of health care healthcare information and a patient’s 
rights to his or her the patient’s medical information shall apply to telehealth interactions. 
 
(g) This section shall not apply to a patient under the jurisdiction of the Department of Corrections 
and Rehabilitation or any other correctional facility. 
 
(h) (1) Notwithstanding any other provision of law and for purposes of this section, the governing 
body of the hospital whose patients are receiving the telehealth services may grant privileges to, 
and verify and approve credentials for, providers of telehealth services based on its medical staff 
recommendations that rely on information provided by the distant-site hospital or telehealth entity, 
as described in Sections 482.12, 482.22, and 485.616 of Title 42 of the Code of Federal 
Regulations. 
 
(2) By enacting this subdivision, it is the intent of the Legislature to authorize a hospital to grant 
privileges to, and verify and approve credentials for, providers of telehealth services as described 
in paragraph (1). 
 
(3) For the purposes of this subdivision, “telehealth” shall include “telemedicine” as the term is 
referenced in Sections 482.12, 482.22, and 485.616 of Title 42 of the Code of Federal Regulations. 
 
SEC. 2. Section 1341.46 is added to the Health and Safety Code, to read: 
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1341.46 (a) There is hereby created the Managed Care Penalty Account within the Managed Care 
Administrative Fines and Penalties Fund. 
 
(b) Moneys in the Managed Care Penalty Account shall be subject to appropriation by the 
Legislature. 
 
(c) Notwithstanding Section 1341.45, fines and administrative penalties collected pursuant to this 
chapter shall be deposited into the Managed Care Penalty Account. 
 
SEC. 3. Section 1374.13 of the Health and Safety Code is amended to read: 
 
1374.13 (a) For the purposes of this section, the definitions in subdivision (a) of Section 2290.5 of 
the Business and Professions Code shall apply. 
 
(b) It is the intent of the Legislature to recognize the practice of telehealth as a legitimate means 
by which an individual may receive health care healthcareservices from a health 
care healthcare provider without in-person contact with the health care healthcare provider. 
 
(c) No A health care service plan shall not require that in-person contact occur between a health 
care healthcare provider and a patient before payment is made for the covered services 
appropriately provided through telehealth, subject to the terms and conditions of the contract 
entered into between the enrollee or subscriber and the health care service plan, and between the 
health care service plan and its participating providers or provider groups. groups, and pursuant 
to Section 1374.14. 
 
(d) No A health care service plan shall not limit the type of setting where services are provided for 
the patient or by the health care healthcare provider before payment is made for the covered 
services appropriately provided through telehealth, subject to the terms and conditions of the 
contract entered into between the enrollee or subscriber and the health care service plan, and 
between the health care service plan and its participating providers or provider groups. groups, 
and pursuant to Section 1374.14. 
 
(e) The requirements of this This section shall also apply to health care service plan and Medi-Cal 
managed care plan contracts with the State Department of Health Care Services pursuant to 
Chapter 7 (commencing with Section 14000) or Chapter 8 (commencing with Section 14200) of 
Part 3 of Division 9 of the Welfare and Institutions Code. 
 
(f) Notwithstanding any other provision, law, this section shall not be interpreted to does 
not authorize a health care service plan to require the use of telehealth when if the health 
care healthcare provider has determined that it is not appropriate. 
 
SEC. 4. Section 1374.14 is added to the Health and Safety Code, to read: 
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1374.14 (a) A contract issued, amended, or renewed on or after January 1, 2020, between a health 
care service plan and a healthcare provider for the provision of healthcare services to an enrollee 
or subscriber shall specify that the health care service plan shall reimburse the treating or 
consulting healthcare provider for the diagnosis, consultation, or treatment of an enrollee or 
subscriber delivered through telehealth services on the same basis and to the same extent that the 
health care service plan is responsible for reimbursement for the same service through in-person 
diagnosis, consultation, or treatment. 
 
(b) (1) A health care service plan contract issued, amended, or renewed on or after January 1, 2020, 
shall specify that the health care service plan shall provide coverage for the cost of healthcare 
services delivered through telehealth services on the same basis and to the same extent that the 
health care service plan is responsible for coverage for the same service through in-person 
diagnosis, consultation, or treatment. Coverage shall not be limited only to services delivered by 
select third-party corporate telehealth providers. 
 
(2) A health care service plan contract issued, amended, or renewed on or after January 1, 2020, 
shall not exclude coverage for a healthcare service solely because the service is delivered through 
telehealth services and not through in-person consultation or contact between a physician and a 
patient, if the service is appropriately delivered through telehealth services. 
 
(c) A health care service plan may offer a contract containing a deductible, copayment, or 
coinsurance requirement for a healthcare service delivered through telehealth services, provided 
that the deductible, copayment, or coinsurance does not exceed the deductible, copayment, or 
coinsurance applicable if the same services were delivered through in-person diagnosis, 
consultation, or treatment. 
 
(d) (1) A health care service plan contract issued, amended, or renewed on or after January 1, 2020, 
shall not impose an annual or lifetime dollar maximum for telehealth services, other than an annual 
or lifetime dollar maximum that applies in the aggregate to all items and services covered under 
the contract. 
 
(2) A health care service plan contract issued, amended, or renewed on or after January 1, 2020, 
shall not impose a deductible, copayment, or coinsurance, or a plan year, calendar year, lifetime, 
or other durational benefit limitation or maximum for benefits or services that is not equally 
imposed on all terms and services covered under the contract. 
 
(e) (1) The director shall, after appropriate notice and opportunity for hearing in accordance with 
the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of 
Division 3 of Title 2 of the Government Code), assess an administrative penalty by order if the 
director determines that a health care service plan has failed to comply with this section. 
 
(2) Notwithstanding Section 1341.45, an administrative penalty collected pursuant to paragraph 
(1) shall be deposited into the Managed Care Penalty Account. 
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(f) The definitions in subdivision (a) of Section 2290.5 of the Business and Professions Code apply  
to this section. 
SEC. 5. Section 10123.85 of the Insurance Code is amended to read: 
 
10123.85 (a) For purposes of this section, the definitions in subdivision (a) of Section 2290.5 of 
the Business and Professions Code shall apply. 
 
(b) It is the intent of the Legislature to recognize the practice of telehealth as a legitimate means 
by which an individual may receive health care healthcareservices from a health 
care healthcare provider without in-person contact with the health care healthcare provider. 
 
(c) No A health insurer shall not require that in-person contact occur between a health 
care healthcare provider and a patient before payment is made for the services appropriately 
provided through telehealth, subject to the terms and conditions of the contract entered into 
between the policyholder or contractholder and the insurer, and between the insurer and its 
participating providers or provider groups. groups, and pursuant to Section 10123.855. 
 
(d) No A health insurer shall not limit the type of setting where services are provided for the patient 
or by the health care healthcare provider before payment is made for the covered services 
appropriately provided by telehealth, subject to the terms and conditions of the contract between 
the policyholder or contract holder and the insurer, and between the insurer and its participating 
providers or provider groups. groups, and pursuant to Section 10123.855. 
 
(e) Notwithstanding any other provision, law, this section shall not be interpreted to does 
not authorize a health insurer to require the use of telehealth when ifthe health 
care healthcare provider has determined that it is not appropriate. 
 
SEC. 6. Section 10123.855 is added to the Insurance Code, to read: 
 
10123.855 (a) A contract issued, amended, or renewed on or after January 1, 2020, between a 
health insurer and a healthcare provider for an alternative rate of payment pursuant to Section 
10133 shall specify that the health insurer shall reimburse the treating or consulting healthcare 
provider for the diagnosis, consultation, or treatment of an insured or policyholder delivered 
through telehealth services on the same basis and to the same extent that the health insurer is 
responsible for reimbursement for the same service through in-person diagnosis, consultation, or 
treatment. 
 
(b) (1) A policy of health insurance issued, amended, or renewed on or after January 1, 2020, that 
provides benefits through contracts with providers at alternative rates of payment shall specify that 
the health insurer shall provide coverage for the cost of healthcare services delivered through 
telehealth services on the same basis and to the same extent that the health insurer is responsible 
for coverage for the same service through in-person diagnosis, consultation, or treatment. 
Analysis of California Assembly Bill 744 
Current as of April 16, 2019 www.chbrp.org A-8 
Coverage shall not be limited only to services delivered by select third-party corporate telehealth 
providers. 
(2) A policy of health insurance issued, amended, or renewed on or after January 1, 2020, that 
provides benefits through contracts with providers at alternative rates of payment shall not exclude 
coverage for a healthcare service solely because the service is delivered through telehealth services 
and not through in-person consultation or contact between a physician and a patient, if the service 
is appropriately delivered through telehealth services. 
 
(c) A health insurer may offer a policy containing a deductible, copayment, or coinsurance 
requirement for a healthcare service delivered through telehealth services, provided that the 
deductible, copayment, or coinsurance does not exceed the deductible, copayment, or coinsurance 
applicable if the same services were delivered through in-person diagnosis, consultation, or 
treatment. 
 
(d) (1) A policy of health insurance issued, amended, or renewed on or after January 1, 2020, shall 
not impose an annual or lifetime dollar maximum for telehealth services, other than an annual or 
lifetime dollar maximum that applies in the aggregate to all items and services covered under the 
policy. 
 
(2) A policy of health insurance issued, amended, or renewed on or after January 1, 2020, shall not 
impose a deductible, copayment, or coinsurance, or a policy year, calendar year, lifetime, or other 
durational benefit limitation or maximum for benefits or services that is not equally imposed on 
all terms and services covered under the policy. 
 
(e) (1) The commissioner shall, after appropriate notice and opportunity for hearing in accordance 
with the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 
of Division 3 of Title 2 of the Government Code), assess an administrative penalty by order if the 
commissioner determines that a health insurer has failed to comply with this section. 
 
(2) An administrative penalty collected pursuant to paragraph (1) shall be deposited into the 
Insurance Fund. 
 
(f) The definitions in subdivision (a) of Section 2290.5 of the Business and Professions Code apply 
to this section. 
 
SEC. 7. Section 14132.725 of the Welfare and Institutions Code is amended to read: 
 
14132.725 (a) To the extent that federal financial participation is available, face-to-face contact 
between a health care provider and a patient is not required under the Medi-Cal program for 
teleophthalmology, teledermatology, and teledentistry by store and forward. Services 
appropriately provided through the store and forward process are subject to billing and 
reimbursement policies developed by the department. 
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(b) For purposes of this section, “teleophthalmology, teledermatology, and teledentistry by store 
and forward” means an asynchronous transmission of medical or dental information to be 
reviewed at a later time by a physician at a distant site who is trained in ophthalmology or 
dermatology or, for teleophthalmology, by an optometrist who is licensed pursuant to Chapter 7 
(commencing with Section 3000) of Division 2 of the Business and Professions Code, or a dentist, 
where the physician, optometrist, or dentist at the distant site reviews the medical or 
dental information without the patient being present in real time. A patient receiving 
teleophthalmology, teledermatology, or teledentistry by store and forward shall be notified of the 
right to receive interactive communication with the distant specialist physician, optometrist, or 
dentist and shall receive an interactive communication with the distant specialist physician, 
optometrist, or dentist, upon request. If requested, communication with the distant specialist 
physician, optometrist, or dentist may occur either at the time of the consultation, or within 30 
days of the patient’s notification of the results of the consultation. If the reviewing optometrist 
identifies a disease or condition requiring consultation or referral pursuant to Section 3041 of the 
Business and Professions Code, that consultation or referral shall be with an ophthalmologist or 
other appropriate physician and surgeon, as required. information. 
 
(c) Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 
2 of the Government Code, the department may implement, interpret, and make specific this 
section by means of all-county letters, provider bulletins, and similar instructions. 
 
SEC. 8. No reimbursement is required by this act pursuant to Section 6 of Article XIII B of the 
California Constitution because the only costs that may be incurred by a local agency or school 
district will be incurred because this act creates a new crime or infraction, eliminates a crime or 
infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 
of the Government Code, or changes the definition of a crime within the meaning of Section 6 of 
Article XIII B of the California Constitution. 
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APPENDIX B  LITERATURE REVIEW METHODS 
This appendix describes methods used in the medical effectiveness literature review conducted for this 
report. A discussion of CHBRP’s system for grading evidence, as well as lists of MeSH Terms, publication 
types, and keywords, follows. 
Studies of the effects of telehealth services were identified through searches of (PubMed, the Cochrane 
Library, Web of Science, EconLit, Business Source Complete, the Cumulative Index of Nursing and Allied 
Health Literature (CINAHL), and PsycINFO. Websites maintained by the following organizations were 
also searched:  Agency for Healthcare Research and Quality; American Cancer Society; American 
College of Obstetricians and Gynecologists; Institute for Clinical Systems Improvement; International 
Network of Agencies for Health Technology Assessment; National Comprehensive Cancer Network, 
Inc.; National Guideline Clearinghouse; National Institute for Clinical Excellence; National Institutes of 
Health; National Health Service Centre for Reviews and Dissemination; Oncofertility Consortium; Scottish 
Intercollegiate Guideline Network; and World Health Organization, the International Network of Agencies 
for Health Technology Assessment (INAHTA), the National Health Service (NHS) Centre for Reviews and 
Dissemination, the National Institute for Health and Clinical Excellence (NICE). 
The search was limited to abstracts of studies published in English. The medical effectiveness search 
was limited to studies published from 2016 to present because CHBRP had previously reviewed this 
literature using the same search terms in 2014, 2015 and 2016 for the SB 289 and AB 2507. The 
literature on the effectiveness of telehealth treatments included multiple randomized controlled trials. The 
majority of the papers cited in the report were systematic reviews and meta-analyses.  
Reviewers screened the title and abstract of each citation retrieved by the literature search to determine 
eligibility for inclusion. The reviewers acquired the full text of articles that were deemed eligible for 
inclusion in the review and reapplied the initial eligibility criteria. 
The literature review returned abstracts for 2719 articles, of which 650 were reviewed for inclusion in this 
report. A total of 41 studies were included in the medical effectiveness review for AB 2507 (2016) and SB 
289.  A total of 66 new studies since 2016 were included in the medical effectiveness review for AB 744.    
Evidence Grading System 
In making a “call” for each outcome measure, the medical effectiveness lead and the content expert 
consider the number of studies as well the strength of the evidence. Further information about the criteria 
CHBRP uses to evaluate evidence of medical effectiveness can be found in CHBRP’s Medical 
Effectiveness Analysis Research Approach.22 To grade the evidence for each outcome measured, the 
team uses a grading system that has the following categories: 
• Research design; 
• Statistical significance; 
• Direction of effect;  
• Size of effect; and 
• Generalizability of findings.  
                                                     
22 Available at: http://chbrp.com/analysis_methodology/medical_effectiveness_analysis.php..  
Analysis of California Assembly Bill 744 
Current as of April 16, 2019 www.chbrp.org B-2 
The grading system also contains an overall conclusion that encompasses findings in these five domains. 
The conclusion is a statement that captures the strength and consistency of the evidence of an 
intervention’s effect on an outcome. The following terms are used to characterize the body of evidence 
regarding an outcome: 
• Clear and convincing evidence; 
• Preponderance of evidence; 
• Limited evidence 
• Inconclusive evidence; and  
• Insufficient evidence. 
A grade of clear and convincing evidence indicates that there are multiple studies of a treatment and that 
the large majority of studies are of high quality and consistently find that the treatment is either effective 
or not effective.  
A grade of preponderance of evidence indicates that the majority of the studies reviewed are consistent in 
their findings that treatment is either effective or not effective.  
A grade of limited evidence indicates that the studies had limited generalizability to the population of 
interest and/or the studies had a fatal flaw in research design or implementation. 
A grade of inconclusive evidence indicates that although some studies included in the medical 
effectiveness review find that a treatment is effective, a similar number of studies of equal quality suggest 
the treatment is not effective. 
A grade of insufficient evidence indicates that there is not enough evidence available to know whether or 
not a treatment is effective, either because there are too few studies of the treatment or because the 
available studies are not of high quality. It does not indicate that a treatment is not effective. 
Search Terms (* indicates truncation of word stem) 
The search terms used to locate studies relevant to AB 744 were as follows: 
Major Subject Heading terms used to search PubMed: 
• Telehealth • Telemedicine 
Keywords used to search PubMed, Cochrane Library, Web of Science, EconLit, and other relevant 
websites:  
• eConsult  
• Remote Consultation 
• Outcome and Process Assessment 
(Health Care) 
• Patient Outcome Assessment 
• Teledermatology 
• Telepsychiatry 
• Telepathology 
• Telerehabilitation 
• Telestroke 
• Patient Reported Outcome Measures 
• Treatment Outcome 
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APPENDIX C  COST IMPACT ANALYSIS: DATA 
SOURCES, CAVEATS, AND ASSUMPTIONS 
The cost analysis in this report was prepared by the members of the cost team, which consists of CHBRP 
task force members and contributors from the University of California, Los Angeles, and the University of 
California, Davis, as well as the contracted actuarial firm, Milliman, Inc. (Milliman).   
Information on the generally used data sources and estimation methods, as well as caveats and 
assumptions generally applicable to CHBRP’s cost impacts analyses are available at CHBRP’s website.   
This appendix describes any analysis-specific data sources, estimation methods, caveats, and 
assumptions used in preparing this cost impact analysis. 
Analysis Specific Caveats and Assumptions 
This subsection discusses the caveats and assumptions relevant specifically to an analysis of AB 744. 
CHBRP projects that AB 744:  
• Will increase use of telehealth services, including both substitution and supplemental services as 
“new to the system” services occur while other telehealth services covered will be related to 
replacing existing services due to convenience. 
• Will increase unit costs as telehealth services are currently reimbursed at a lower amount than 
the in-person equivalent, and AB 744 mandates reimbursement to be “on the same basis and to 
the same extent the plans and policies reimburse for the same service through in-person 
diagnosis, consultation, or treatment”. CHBRP interprets this provision as mandating equal 
reimbursement for equivalent services delivered either through telehealth or in-person. 
• Will have an impact on enrollee out-of-pocket expenses for covered benefits (e.g. deductibles, 
copayments) to attain “parity” of coverage. We assume that health plans and insurers would 
charge the same copays or coinsurance for telehealth services compared to the equivalent in-
person service.  
The following is a description of methodology and assumptions used to develop the estimates of cost 
impacts: 
• CHBRP determined the current coverage percentage of telehealth services based on carrier 
survey responses. Carriers that currently cover telehealth services are assumed to have no 
change in their utilization. The projected change in utilization was applied to carriers’ population 
associated with coverage expansion for each service category.  
• CHBRP identified service categories for which there is an applicable telehealth modality (e.g. live 
video visits; store and forward, etc.) and may have telehealth claims. CHBRP then used 
CPT/HCPCS procedure codes that were available in Milliman’s proprietary 2016 Consolidated 
Health Cost Guidelines Sources Database (CHSD), which contains both commercial claims and 
Medi-Cal managed care encounters to identify procedures currently delivered via telehealth, and 
services in the category that are not delivered via telehealth. Methods for identifying relevant 
codes were vetted by content experts and by relevant carrier responses. The table below lists the 
relevant codes used for this analysis. Note, in addition to the codes listed below, we also 
considered any claims that included the modifier GT or GQ to always be telehealth. “GT” signifies 
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the service was delivered via interactive audio and video telecommunications systems while 
modifier “GQ” signifies that the service was delivered via an asynchronous (or “store and 
forward”) telecommunications system. We used this method since these were the modifiers 
available for providers use in 2016.  
Table 9. CPT/HCPCS Codes Used for the AB 744 Analysis, Always Considered to Be Telehealth 
CPT/HCPCS Codes That 
Are Always Telehealth 
Description 
93733 Telephone analy, pacemaker 
98966 Hc pro phone call 5-10 min 
98967 Hc pro phone call 11-20 min 
98968 Hc pro phone call 21-30 min 
99091 Collj & interpj data ea 30 d 
99371 Physician phone consultation 
99372 Physician phone consultation 
99373 Physician phone consultation 
99441 Phone e/m phys/qhp 5-10 min 
99442 Phone e/m phys/qhp 11-20 min 
99443 Phone e/m phys/qhp 21-30 min 
99444 Online e/m by phys/qhp 
99446 Ntrprof ph1/ntrnet/ehr 5-10 
99447 Ntrprof ph1/ntrnet/ehr 11-20 
99448 Ntrprof ph1/ntrnet/ehr 21-30 
99449 Ntrprof ph1/ntrnet/ehr 31/> 
99451 Ntrprof Ph1/Ntrnet/Ehr 5/> 
99452 Ntrprof Ph1/Ntrnet/Ehr Rfrl 
0188T Videoconf crit care 74 min 
0189T Videoconf crit care addl 30 
D9995 Teledentistry real-time 
D9996 Teledentistry dent review 
G0406 Inpt/tele follow up 15 
G0407 Inpt/tele follow up 25 
G0408 Inpt/tele follow up 35 
G0425 Inpt/ED teleconsult30 
G0426 Inpt/ED teleconsult50 
G0427 Inpt/ED teleconsult70 
G0459 Telehealth inpt pharm mgmt 
G0508 Crit care telehea consult 60 
G0509 Crit care telehea consult 50 
Q3014 Telehealth facility fee 
S0320 RN telephone calls to DMP 
S9109 CHF telemonitoring month 
S9110 Telemonitoring/home per mnth 
T1014 Telehealth transmit, per min 
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• Current claims data for telehealth services underestimates true utilization of these services for a 
variety of reasons: (1) Many enrollees subject to AB 744 do not have coverage for these services. 
However, enrollees without coverage may still use telehealth services by paying telehealth 
vendors directly for services at the point of care. Non-covered services would not be reflected in 
claims data. (2) Billing practices among providers may vary depending on the market segment 
and carriers’ coverage policy. (3) In general there is underuse of the GT modifier. According to a 
GAO (2017) report, “CMS officials told us that there are no payment incentives for a provider to 
put a telehealth modifier on a non-approved telehealth service, because the provider could 
receive payment for that service if it did not include the modifier and the service is payable under 
Medicare’s Physician Fee Schedule. That is, the payment to a distant site provider for a service 
on the approved telehealth list would be the same amount as the payment for the service if it 
were furnished in person. Adding a telehealth modifier incorrectly also increases the possibility 
that claim would be examined, CMS officials said, reducing the incentive to incorrectly add the 
telehealth modifier.”  (4) Coding and reimbursement rules for telehealth services are evolving. For 
example, in 2017 the Place of Service code set was revised to allow for a telehealth place of 
service code (02).  
• Because existing claims data are an unreliable source of current utilization rates of telehealth 
services, CHBRP used information from Kaiser Permanente Northern California (KPNC) to 
estimate utilization as the KPNC experience is one of the only well-documented examination of 
utilization of telehealth visits between physicians and patients for the California region (Pearl, 
2014). The evaluation occurred over the period of time between 2008 (at the introduction of a 
telehealth strategy that included phone, secure e-mail, and live videoconference visits went into 
effect) and 2013. KPNC’s experience indicates about 22.8% of all services that have an 
associated telehealth modality are provided via telehealth. However, we recognize that KPNC’s 
utilization rates are likely to be higher than average since KPNC has been promoting the adoption 
of telehealth for many years and can do so more seamlessly than other health plans and insurers, 
given that it is an integrated delivery system and their providers have telehealth capabilities built 
into their workflows. Therefore, CHBRP applies a dampening factor of 75% such that predicted 
use of telehealth in Year 1 would be 25% of the KPNC experience in Year 1. The rationale for this 
adjustment is based on the GAO study, although CHBRP used a reasonable dampening factor 
based on judgement. At baseline, therefore the population with coverage is estimated to have a 
5.7% utilization rate among all visits in Year 1. The population without coverage is assumed to 
have 0% utilization rate at the baseline, across all modalities and service categories. 
Postmandate, the population without coverage is estimated to experience increased utilization to 
match the utilization rate of those with coverage. For the second year, we also relied on KPNC 
experience indicating about 26.1% of all services that have an associated telehealth modality are 
provided via telehealth. After applying the dampening factor, the utilization rate for those with 
coverage is expected to be 6.54% for Year 2.  
• CHBRP assumes that substitute services constitute 29% of all new telehealth outpatient visits 
services (i.e., replacing in-person services of equivalent severity and time), while supplementary 
telehealth services would constitute 71% (i.e., additional services that were previously provided 
but not reimbursed, or not previously provided.) The 29% is estimated from Shah et al. (2018) 
which found that “for every 3.5 virtual visits performed, an in-person visit was averted.” CHBRP 
acknowledges that one limitation of this study is that its population is not necessarily 
generalizable given that it was focused on an ACO population with neurological conditions. 
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However, it is one of the most recent studies that examines substitution effects for a covered 
population.  
• As noted above, AB 744 requires plans and insurers to reimburse telehealth services on the 
same basis and to the same extent as in-person services. It is not likely that plans/insurers 
reimburse telehealth services at the level of an in-person visit presently. Therefore we calculated 
a per-unit cost increase for each applicable healthcare service category. The average per-unit 
increase for professional services associated with telehealth and in-person visit are presented in 
Table 1. Note, that in some instances we do not estimate a change in per-unit cost. This is 
because of insufficient data for claims that can be identified as telehealth. If there is no way to 
identify differential payment for a service category, we assume no change in per-unit cost 
postmandate. 
• A significant portion of radiology and lab/pathology are provided via “store and forward” 
technology or via new home kits related to a telehealth visit. However, the claims data do not 
show a material amount of telehealth related claims for these service categories. It is likely that 
radiologist and pathologists are not coding these services as telehealth and payments and 
coverage for these services are treated the same regardless as to whether they are provided in-
person or via telehealth modalities. It is not likely that such coding practices will change. Thus we 
estimate no change in utilization for these categories of services. In addition, there is no way to 
identify differential payment for these service categories, so we assume no change in per-unit 
cost postmandate.  
• We understand that there are certain telehealth services, such as tele-ICU and tele-stroke, that 
may be included in inpatient or outpatient fees. Inpatient facility services (e.g. remote monitoring 
in an ICU) are generally bundled in per diem or per case rates payments and we assume that 
these services would be continued to be bundled and reimbursed per current billing practices. 
Therefore we assume no change in cost for these services. For related inpatient and outpatient 
professional services, the claims data do not show a material amount of telehealth related claims 
for these service categories. While providers may be providing some of these services using 
interprofessional consultation (e.g. peer to peer consults or e-consults), providers are not coding 
these services as telehealth. Thus, if there is no way to identify differential payment for a service 
category, we assume no change in per-unit cost postmandate. CHBRP assumes that these 
inpatient-focused telehealth services, which are part of services delivered for significant injuries or 
conditions, will not be supplemental, but will instead substitute for the equivalent in-person 
service.  
• CHBRP excluded service categories with limited telehealth modality application. For example, 
CHBRP considered telehealth services that may be applicable for preventive services. However, 
claims data revealed limited to no telehealth use for preventive services. This can likely be 
explained by the nature of most preventive services which typically requires an in-person service 
or procedure (for example, immunizations, physical exams, pap tests, colonoscopies, etc.).   
• CHBRP used an annual cost trend assumption of 2.0%. This is based on the December 2018 
published medical care index, which is a component of the Consumer Price Index. 
• In Table 1, CHBRP presents differential impacts for Medi-Cal managed care and commercially 
insured markets. It is important to note that the average unit cost information for the Medi-Cal 
markets are based on encounter data. Encounter data are used for reporting health care use and 
are not directly for payment as claims data are. Data quality issues related to encounter data are 
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well-documented.23 24 Therefore, comparisons of average unit costs should be made within rather 
than across market segments since data sources are not comparable.  
Determining Public Demand for the Proposed Mandate 
This subsection discusses public demand for the benefits AB 744 would mandate. Considering the criteria 
specified by CHBRP’s authorizing statute, CHBRP reviews public demand for benefits relevant to a 
proposed mandate in two ways. CHBRP: 
• Considers the bargaining history of organized labor; and 
• Compares the benefits provided by self-insured health plans or policies (which are not regulated 
by the DMHC or CDI and therefore not subject to state-level mandates) with the benefits that are 
provided by plans or policies that would be subject to the mandate. 
On the basis of conversations with the largest collective bargaining agents in California, CHBRP 
concluded that unions currently do not include cost-sharing arrangements for telehealth, by its existing 
definition. In general, unions negotiate for broader contract provisions such as coverage for dependents, 
premiums, deductibles, and broad coinsurance levels. Among publicly funded self-insured health 
insurance policies, the preferred provider organization (PPO) plans offered by CalPERS currently have 
the largest number of enrollees. The CalPERS PPOs currently provide benefit coverage similar to what is 
available through group health insurance plans and policies that would be subject to the mandate. 
To further investigate public demand, CHBRP used the bill-specific coverage survey to ask carriers who 
act as third-party administrators for (non-CalPERS) self-insured group health insurance programs 
whether the relevant benefit coverage differed from what is offered in group market plans or policies that 
would be subject to the mandate. The majority of plan respondents did not act as third-party 
administrators for self-insured group health insurance programs; it is unclear whether benefit coverage 
differs in this segment. 
Second Year Impacts on Benefit Coverage, Utilization, and Cost 
In order to develop Table 10, CHBRP has considered whether continued implementation during the 
second year of the benefit coverage requirements of AB 744 would have a substantially different impact 
on utilization of either the tests, treatments or services for which coverage was directly addressed, the 
utilization of any indirectly affected utilization, or both. To generate this table, CHBRP reviewed the 
literature and consulted content experts about the possibility of varied second year impacts and applied 
what was learned to a projection of a second year of implementation.   
As displayed in Table 10, the second year’s impacts of AB 744 would be similar to the impacts in the first 
year (see Table 1). The increases in total expenditures and premiums are due to increased adoption and 
use of telehealth over time, as well an annual trend increase as described above.  
                                                     
23 IHA (June 2018) Challenges in Encounter Data Submissions. Available at: 
https://www.iha.org/sites/default/files/resources/encounter_data_white_paper_final.pdf.  
24 GAO (January 2017) Medicaid: Program Oversight Hampered by Data Challenges, Underscoring Need for 
Continued Improvements.  
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Table 10. AB 744 Impacts on Benefit Coverage, Utilization, and Cost, 2021 
  Baseline Postmandate Increase/ 
Decrease 
Percentage 
Change 
Benefit coverage 
 Total enrollees with health 
insurance subject to state-level 
benefit mandates (a) 24,490,000 24,490,000 0 0% 
 Total enrollees with health 
insurance subject to AB 744 24,490,000 24,490,000 0 0% 
 Have telehealth coverage for service category:         
 … Office visits – primary care 
and urgent care visits 
56.1% 100.0% 44% 78% 
 … Office visits – ophthalmology 70.4% 100.0% 30% 42% 
 … Office visits – dermatology 70.4% 100.0% 30% 42% 
 … Office visits – other specialists 70.4% 100.0% 30% 42% 
 … Emergency department visits 55.7% 100.0% 44% 80% 
 … Cardiovascular 61.3% 100.0% 39% 63% 
 … Radiology 50.9% 100.0% 49% 96% 
 … Lab/pathology 50.9% 100.0% 49% 96% 
 … Outpatient mental health and 
SUD 
80.3% 100.0% 20% 25% 
Utilization and unit cost 
 Commercial and CalPERS HMOs     
  Average utilization per 1,000 for 
telehealth services for service 
category         
 Telehealth services         
 … Office visits – primary care 
and urgent care visits 61.1 75.2 14.0 23% 
 … Office visits – ophthalmology, 
dermatology, and other 
specialists 54.5 67.0 12.5 23% 
 … Outpatient mental health and 
SUD 35.2 43.3 8.1 23% 
 … Emergency department visits, 
diagnostic services and other 
services 14.6 18.1 3.4 23% 
 In-person services         
 … Office visits – primary care 
and urgent care visits 1,078.9 1,074.8 -4.1 0% 
 … Office visits – ophthalmology, 
dermatology, and other 
specialists 962.2 958.5 -3.6 0% 
 … Outpatient mental health and 
SUD 621.1 618.7 -2.4 0% 
 … Emergency department visits, 
diagnostic services and other 
services 4,007.0 4,006.0 -1.0 0% 
  Average cost per telehealth 
service for service category         
 Telehealth services         
 … Office visits – primary care 
and urgent care visits $58 $137 $79 137% 
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 … Office visits – ophthalmology, 
dermatology, and other 
specialists $67 $140 $73 109% 
 … Outpatient mental health and 
SUD $107 $151 $44 42% 
 … Emergency department visits, 
diagnostic services and other 
services $190 $191 $0 0% 
 In-person services         
 … Office visits – primary care 
and urgent care visits $137 $137 $0 0% 
 … Office visits – ophthalmology, 
dermatology, and other 
specialists $140 $140 $0 0% 
 … Outpatient mental health and 
SUD $151 $151 $0 0% 
 … Emergency department visits, 
diagnostic services and other 
services $60 $60 $0 0% 
 Medi-Cal Managed Care Plans     
  Average utilization per 1,000 for 
telehealth services for service 
category         
 Telehealth services         
 … Office visits – primary care 
and urgent care visits 0.0 59.6 59.6 N/A 
 … Office visits – ophthalmology, 
dermatology, and other 
specialists 37.7 81.8 44.1 117% 
 … Outpatient mental health and 
SUD 8.9 11.4 2.5 28% 
 … Emergency department visits, 
diagnostic services and other 
services 2.8 47.6 44.9 1619% 
 In-person services         
 … Office visits – primary care 
and urgent care visits 869.5 852.1 -17.4 -2% 
 … Office visits – ophthalmology, 
dermatology, and other 
specialists 1,182.9 1,170.0 -12.9 -1% 
 … Outpatient mental health and 
SUD 163.1 162.4 -0.7 0% 
 … Emergency department visits, 
diagnostic services and other 
services 5,551.5 5,538.4 -13.1 0% 
  Average cost per telehealth 
service for service category         
 Telehealth services         
 … Office visits – primary care 
and urgent care visits $37 $37 $0 0% 
 … Office visits – ophthalmology, 
dermatology, and other 
specialists $42 $49 $7 15% 
 … Outpatient mental health and 
SUD $89 $89 $0 0% 
 … Emergency department visits, 
diagnostic services and other 
services $54 $70 $16 30% 
 In-person services         
 … Office visits – primary care 
and urgent care visits $37 $37 $0 0% 
 … Office visits – ophthalmology, 
dermatology, and other 
specialists $49 $49 $0 0% 
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 … Outpatient mental health and 
SUD $89 $89 $0 0% 
 … Emergency department visits, 
diagnostic services and other 
services $29 $29 $0 0% 
Expenditures 
Premiums by payer 
 Private employers for group 
insurance 
$86,438,375,000 $86,570,790,000 $132,415,000 0.1532% 
 CalPERS HMO employer 
expenditures (c) (b) 
$3,098,551,000 $3,103,430,000 $4,879,000 0.1575% 
 Medi-Cal Managed Care Plan 
expenditures 
$28,492,273,000 $28,534,474,000 $42,201,000 0.1481% 
 Enrollees with individually 
purchased insurance 
$12,045,324,000 $12,072,055,000 $26,731,000 0.2219% 
 Enrollees with group insurance, 
CalPERS HMOs, Covered 
California, and Medi-Cal 
Managed Care (c) 
$2,486,222,000 $2,490,427,000 $4,205,000 0.1691% 
Enrollee expenses 
 For covered benefits 
(deductibles, copayments, etc.) 
$14,750,880,000 $14,800,326,000 $49,446,000 0.3352% 
 For noncovered benefits (d) $0 $0 $0 0.00% 
Total expenditures $159,301,797,000 $159,301,797,000 $159,580,095,000 0.1747% 
Source: California Health Benefits Review Program, 2019. 
Notes: (a) Enrollees in plans and policies regulated by DMHC or CDI aged 0 to 64 years as well as enrollees 65 years or older in 
employer-sponsored health insurance.  This group includes commercial enrollees (including those associated with Covered 
California or CalPERS) and Medi-Cal beneficiaries enrolled in DMHC-regulated plans.25  
(b) Approximately 56.17% of CalPERS enrollees in DMHC-regulated plans are state retirees, state employees, or their dependents.  
(c) Enrollee premium expenditures include contributions by employees to employer-sponsored health insurance, health insurance 
purchased through Covered California, and contributions to Medi-Cal Managed Care. 
(d) Includes only expenses paid directly by enrollees (or other sources) to providers for services related to the mandated benefit that 
are not currently covered by insurance. This only includes those expenses that will be newly covered postmandate. Other 
components of expenditures in this table include all health care services covered by insurance. 
Key: CalPERS  = California Public Employees’ Retirement System; CDI = California Department of Insurance; DMHC = Department 
of Managed Health Care; HMO = Health Maintenance Organizations; SUD = substance use disorder.
                                                     
25 For more detail, see Estimates of Sources of Health Insurance in California, available at  
http://chbrp.com/analysis_methodology/cost_impact_analysis.php.   
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